| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX47 MYH7 MYH8 RTEL1 RAD54L2 ABCC8 VCP SLC27A3 MRE11 EP400 ATP13A1 VPS4B MYO18A DDX56 YTHDC2 ATP13A2 DICER1 ATP10D GET3 HLTF | 2.56e-05 | 614 | 227 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | helicase activity | 8.38e-05 | 158 | 227 | 9 | GO:0004386 | |
| GeneOntologyMolecularFunction | diacyl lipopeptide binding | 1.29e-04 | 2 | 227 | 2 | GO:0042498 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX47 MYH7 MYH8 RTEL1 RAD54L2 ABCC8 VCP ATP13A1 VPS4B MYO18A DDX56 YTHDC2 ATP13A2 ATP10D GET3 | 1.68e-04 | 441 | 227 | 15 | GO:0016887 |
| GeneOntologyBiologicalProcess | negative regulation of transcription of nucleolar large rRNA by RNA polymerase I | 5.29e-06 | 4 | 228 | 3 | GO:1901837 | |
| GeneOntologyBiologicalProcess | positive regulation of centriole elongation | 1.31e-05 | 5 | 228 | 3 | GO:1903724 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G2/M phase transition | 1.55e-05 | 131 | 228 | 9 | GO:1902749 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle G2/M phase transition | 2.29e-05 | 77 | 228 | 7 | GO:1902750 | |
| GeneOntologyBiologicalProcess | regulation of G2/M transition of mitotic cell cycle | 4.50e-05 | 116 | 228 | 8 | GO:0010389 | |
| GeneOntologyBiologicalProcess | regulation of centriole elongation | 4.52e-05 | 7 | 228 | 3 | GO:1903722 | |
| GeneOntologyBiologicalProcess | chromatin organization | MTA2 JDP2 RAD54L2 BCOR ZNF462 BRCA1 USP7 KDM2B MACROH2A2 MRE11 DCAF13 EP400 L3MBTL2 C6orf89 KAT6A BAZ1B MACROH2A1 DICER1 WDHD1 TET1 HLTF EHMT1 GATAD1 ZNF518B | 5.93e-05 | 896 | 228 | 24 | GO:0006325 |
| GeneOntologyBiologicalProcess | centriole elongation | 7.17e-05 | 8 | 228 | 3 | GO:0061511 | |
| GeneOntologyBiologicalProcess | mitotic G2 DNA damage checkpoint signaling | 7.58e-05 | 40 | 228 | 5 | GO:0007095 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | MTA2 JDP2 RAD54L2 BCOR BRCA1 USP7 KDM2B MACROH2A2 MRE11 DCAF13 EP400 C6orf89 KAT6A BAZ1B MACROH2A1 DICER1 WDHD1 TET1 HLTF EHMT1 GATAD1 | 8.01e-05 | 741 | 228 | 21 | GO:0006338 |
| GeneOntologyBiologicalProcess | positive regulation of centriole replication | 1.07e-04 | 9 | 228 | 3 | GO:0046601 | |
| GeneOntologyBiologicalProcess | regulation of protein K63-linked deubiquitination | 1.22e-04 | 2 | 228 | 2 | GO:1903004 | |
| GeneOntologyBiologicalProcess | positive regulation of protein K63-linked deubiquitination | 1.22e-04 | 2 | 228 | 2 | GO:1903006 | |
| GeneOntologyBiologicalProcess | toll-like receptor TLR6:TLR2 signaling pathway | 1.22e-04 | 2 | 228 | 2 | GO:0038124 | |
| GeneOntologyBiologicalProcess | detection of diacyl bacterial lipopeptide | 1.22e-04 | 2 | 228 | 2 | GO:0042496 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MTA2 JDP2 RAD54L2 BCOR ZNF462 BRCA1 USP7 KDM2B MACROH2A2 TAF4 MRE11 DCAF13 EP400 L3MBTL2 C6orf89 KAT6A BAZ1B MACROH2A1 DICER1 WDHD1 TET1 HLTF EHMT1 GATAD1 ZNF518B | 1.22e-04 | 999 | 228 | 25 | GO:0071824 |
| GeneOntologyBiologicalProcess | cell cycle G2/M phase transition | 1.24e-04 | 171 | 228 | 9 | GO:0044839 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | DAB2IP ANKRD31 STOX1 WNK1 ADARB1 CEP120 BRCA1 BOP1 FGFR3 EXOC7 FHL1 PLK1 ALOX15B MRE11 EP400 C6orf89 NOP53 VPS4B BAZ1B YTHDC2 TRIM39 MACROH2A1 NUPR1 DICER1 E2F8 PRCC CDK13 CEP295 FBXW7 | 1.39e-04 | 1256 | 228 | 29 | GO:0051726 |
| GeneOntologyBiologicalProcess | negative regulation of cell development | DNAJB11 GPR55 PF4 TTPA NF1 ABCC8 FGFR3 FOXJ1 DICER1 ACTR3 SLIT1 LRP4 FBXW7 | 1.63e-04 | 353 | 228 | 13 | GO:0010721 |
| GeneOntologyBiologicalProcess | regulation of centriole replication | 1.80e-04 | 26 | 228 | 4 | GO:0046599 | |
| GeneOntologyBiologicalProcess | negative regulation of G2/M transition of mitotic cell cycle | 1.82e-04 | 75 | 228 | 6 | GO:0010972 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase I | 2.06e-04 | 11 | 228 | 3 | GO:0016479 | |
| GeneOntologyBiologicalProcess | negative regulation of nervous system development | 2.16e-04 | 184 | 228 | 9 | GO:0051961 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | MYH7 OBSCN WNK1 CEP120 BRCA1 BOP1 PISD PLK1 DCAF13 NOP53 VPS4B DICER1 USP10 CEP295 MYBPC3 | 2.77e-04 | 475 | 228 | 15 | GO:0140694 |
| GeneOntologyBiologicalProcess | cell cycle process | DAB2IP ANKRD31 RTEL1 RIOK3 STOX1 WNK1 CEP120 BRCA1 FES FGFR3 EXOC7 FHL1 PLK1 ZNF541 VCP MRE11 DCAF13 NOP53 POLE VPS4B BAZ1B YTHDC2 TRIM39 MACROH2A1 DICER1 ACTR3 E2F8 BROX CEP295 SKA3 FBXW7 | 2.83e-04 | 1441 | 228 | 31 | GO:0022402 |
| GeneOntologyBiologicalProcess | G2/M transition of mitotic cell cycle | 2.95e-04 | 152 | 228 | 8 | GO:0000086 | |
| GeneOntologyCellularComponent | myosin filament | 6.71e-06 | 25 | 229 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | nuclear chromosome | BRCA1 MACROH2A2 PLK1 MRE11 EP400 PHF12 POLE BAZ1B MACROH2A1 WDHD1 PRIM1 TET1 | 2.53e-05 | 254 | 229 | 12 | GO:0000228 |
| GeneOntologyCellularComponent | Toll-like receptor 2-Toll-like receptor 6 protein complex | 1.19e-04 | 2 | 229 | 2 | GO:0035355 | |
| Domain | DOCK_N | 1.76e-05 | 5 | 228 | 3 | PF16172 | |
| Domain | DOCK_N | 1.76e-05 | 5 | 228 | 3 | IPR032376 | |
| Domain | ANATO | 6.06e-05 | 7 | 228 | 3 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 6.06e-05 | 7 | 228 | 3 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 6.06e-05 | 7 | 228 | 3 | PS01177 | |
| Domain | ANATO | 6.06e-05 | 7 | 228 | 3 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 6.06e-05 | 7 | 228 | 3 | IPR000020 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 9.61e-05 | 8 | 228 | 3 | IPR019565 | |
| Domain | Thiol-ester_cl | 9.61e-05 | 8 | 228 | 3 | PF10569 | |
| Domain | MacrogloblnA2_CS | 9.61e-05 | 8 | 228 | 3 | IPR019742 | |
| Domain | Core_histone_macro-H2A | 1.48e-04 | 2 | 228 | 2 | IPR021171 | |
| Domain | A2M | 2.02e-04 | 10 | 228 | 3 | PF00207 | |
| Domain | A2M_N_2 | 2.02e-04 | 10 | 228 | 3 | IPR011625 | |
| Domain | A2M_comp | 2.02e-04 | 10 | 228 | 3 | IPR011626 | |
| Domain | A2M_recep | 2.02e-04 | 10 | 228 | 3 | PF07677 | |
| Domain | A2M_comp | 2.02e-04 | 10 | 228 | 3 | PF07678 | |
| Domain | A2M_N | 2.02e-04 | 10 | 228 | 3 | PF01835 | |
| Domain | A2M_N | 2.02e-04 | 10 | 228 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.02e-04 | 10 | 228 | 3 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.02e-04 | 10 | 228 | 3 | PS00477 | |
| Domain | A2M_N_2 | 2.02e-04 | 10 | 228 | 3 | PF07703 | |
| Domain | Macroglobln_a2 | 2.02e-04 | 10 | 228 | 3 | IPR001599 | |
| Domain | DHR-1_domain | 2.76e-04 | 11 | 228 | 3 | IPR027007 | |
| Domain | DHR_2 | 2.76e-04 | 11 | 228 | 3 | PS51651 | |
| Domain | DHR_1 | 2.76e-04 | 11 | 228 | 3 | PS51650 | |
| Domain | DHR-2 | 2.76e-04 | 11 | 228 | 3 | PF06920 | |
| Domain | DOCK | 2.76e-04 | 11 | 228 | 3 | IPR026791 | |
| Domain | DOCK_C | 2.76e-04 | 11 | 228 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 2.76e-04 | 11 | 228 | 3 | PF14429 | |
| Domain | DHR-2 | 2.76e-04 | 11 | 228 | 3 | IPR027357 | |
| Domain | Helicase_C | 3.42e-04 | 107 | 228 | 7 | PF00271 | |
| Domain | HELICc | 3.42e-04 | 107 | 228 | 7 | SM00490 | |
| Domain | Helicase_C | 3.62e-04 | 108 | 228 | 7 | IPR001650 | |
| Domain | HELICASE_CTER | 3.82e-04 | 109 | 228 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.82e-04 | 109 | 228 | 7 | PS51192 | |
| Domain | DEXDc | 3.82e-04 | 109 | 228 | 7 | SM00487 | |
| Domain | Helicase_ATP-bd | 4.04e-04 | 110 | 228 | 7 | IPR014001 | |
| Domain | CAC1F_C | 4.42e-04 | 3 | 228 | 2 | IPR031688 | |
| Domain | CAC1F_C | 4.42e-04 | 3 | 228 | 2 | PF16885 | |
| Domain | Ig_I-set | 5.59e-04 | 190 | 228 | 9 | IPR013098 | |
| Domain | I-set | 5.59e-04 | 190 | 228 | 9 | PF07679 | |
| Domain | VDCC_L_a1su | 8.76e-04 | 4 | 228 | 2 | IPR005446 | |
| Domain | Myosin_tail_1 | 1.28e-03 | 18 | 228 | 3 | PF01576 | |
| Domain | Myosin_tail | 1.28e-03 | 18 | 228 | 3 | IPR002928 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 1.28e-03 | 18 | 228 | 3 | IPR008930 | |
| Domain | - | IGFN1 TRIO OBSCN CMYA5 IL18RAP VSTM4 IGSF22 NFATC3 FGFR3 KIR2DL2 CAMTA1 KIR2DS1 CDON SEMA3C PKHD1L1 HMCN1 TNXB MYBPC3 | 1.35e-03 | 663 | 228 | 18 | 2.60.40.10 |
| Domain | Anaphylatoxin_comp_syst | 1.45e-03 | 5 | 228 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.45e-03 | 5 | 228 | 2 | IPR001840 | |
| Domain | Toll-like_receptor | 1.45e-03 | 5 | 228 | 2 | IPR017241 | |
| Domain | P-type_TPase_V | 1.45e-03 | 5 | 228 | 2 | IPR006544 | |
| Domain | Acyltransf_C | 1.45e-03 | 5 | 228 | 2 | PF16076 | |
| Domain | TIF_beta_prop-like | 1.45e-03 | 5 | 228 | 2 | IPR013979 | |
| Domain | eIF2A | 1.45e-03 | 5 | 228 | 2 | PF08662 | |
| Domain | Acyltransf_C | 1.45e-03 | 5 | 228 | 2 | IPR032098 | |
| Domain | Myosin-like_IQ_dom | 1.51e-03 | 19 | 228 | 3 | IPR027401 | |
| Domain | - | 1.51e-03 | 19 | 228 | 3 | 4.10.270.10 | |
| Domain | PDZ | 1.75e-03 | 141 | 228 | 7 | PF00595 | |
| Domain | TIR | 2.03e-03 | 21 | 228 | 3 | SM00255 | |
| Domain | IG | IGFN1 TRIO OBSCN IL18RAP VSTM4 IGSF22 FGFR3 KIR2DL2 KIR2DS1 CDON SEMA3C HMCN1 MYBPC3 | 2.08e-03 | 421 | 228 | 13 | SM00409 |
| Domain | Ig_sub | IGFN1 TRIO OBSCN IL18RAP VSTM4 IGSF22 FGFR3 KIR2DL2 KIR2DS1 CDON SEMA3C HMCN1 MYBPC3 | 2.08e-03 | 421 | 228 | 13 | IPR003599 |
| Domain | RIH_assoc-dom | 2.15e-03 | 6 | 228 | 2 | IPR013662 | |
| Domain | OSR1_C | 2.15e-03 | 6 | 228 | 2 | PF12202 | |
| Domain | Ins145_P3_rec | 2.15e-03 | 6 | 228 | 2 | PF08709 | |
| Domain | RIH_assoc | 2.15e-03 | 6 | 228 | 2 | PF08454 | |
| Domain | Kinase_OSR1/WNK_CCT | 2.15e-03 | 6 | 228 | 2 | IPR024678 | |
| Domain | RIH_dom | 2.15e-03 | 6 | 228 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.15e-03 | 6 | 228 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.15e-03 | 6 | 228 | 2 | IPR015925 | |
| Domain | - | 2.15e-03 | 6 | 228 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 2.15e-03 | 6 | 228 | 2 | PF01365 | |
| Domain | PDZ | 2.30e-03 | 148 | 228 | 7 | SM00228 | |
| Domain | TIR | 2.33e-03 | 22 | 228 | 3 | PF01582 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP MTA2 MORN1 TRIO OBSCN PSMB10 WNK1 NPHP4 STK11IP ZC3H11A AHNAK EIF2B3 INTS11 USP7 ARC WNK2 DOCK3 PNPLA2 EP400 ATP13A1 PHF12 POLE POLG KAT6A ARHGAP17 DDX56 MED13L ATP13A2 C6orf132 HIVEP3 MYOF CDK13 CSPG4 EHMT1 LRP4 CEP170B | 5.07e-15 | 1105 | 234 | 36 | 35748872 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MORN1 TRIO RTEL1 AGPAT3 ARHGEF38 OBSCN DGKH ADARB1 ADCY1 ZNF461 ZNF462 ESYT2 ZC3H11A ABCC8 PISD MACROH2A2 TAF4 CAMTA1 WNK2 DOCK1 DDR1 PTBP2 POLG KAT6A DDX56 MACROH2A1 RBM39 HIVEP3 PACS1 USP10 TJP1 CDK13 TBK1 XPNPEP3 SFXN3 EHMT1 HPS5 CATSPERG CEP170B PDZD2 | 7.30e-14 | 1489 | 234 | 40 | 28611215 |
| Pubmed | BCOR ESYT2 ZC3H11A BRCA1 INTS11 USP7 KDM2B AFDN BOP1 TAF4 CSTF2T MRE11 SEMA3C SLC4A7 EP400 ATP13A1 NOP53 PHF12 ARHGEF12 BAZ1B DDX56 YTHDC2 SPECC1 DICER1 C6orf132 USP10 MYOF HARS2 TBC1D10A CDK13 HLTF EHMT1 GATAD1 PARN MRPL9 CEP170B | 3.49e-11 | 1497 | 234 | 36 | 31527615 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DDX47 MTA2 TRIO PFKM CMYA5 ZC3H11A NF1 INTS11 USP7 AFDN BOP1 FHL1 MRE11 IRS4 DCAF13 ATP13A1 NOP53 POLE ZNF280C BAZ1B DDX56 YTHDC2 MACROH2A1 PDIA3 DICER1 ACTR3 RBM39 USP10 UTP18 PRIM1 TBK1 SFXN3 EHMT1 SLIRP | 1.61e-10 | 1425 | 234 | 34 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DDX47 MTA2 DNAJB11 RIOK3 PFKM ZC3H11A NF1 AHNAK EIF2B3 INTS11 USP7 AFDN BOP1 MACROH2A2 PLK1 VCP MRE11 DCAF13 EP400 L3MBTL2 POLE ADNP2 BAZ1B DDX56 MACROH2A1 PDIA3 ACTR3 RBM39 UTP18 SFXN3 HLTF SORD | 7.32e-10 | 1353 | 234 | 32 | 29467282 |
| Pubmed | MTA2 ZC3H11A NF1 AHNAK USP7 AFDN BOP1 VCP MRE11 IRS4 DCAF13 NOP53 POLE BAZ1B DDX56 YTHDC2 DICER1 ACTR3 RBM39 UTP18 TJP1 PARN | 7.67e-10 | 653 | 234 | 22 | 22586326 | |
| Pubmed | DDX47 MTA2 PI4K2B DNAJB11 AGPAT4 PFKM JMY ITPR1 ESYT2 AHNAK EIF2B3 USP7 EXOC7 VCP IRS4 NOP53 PIGS DDX56 YTHDC2 SPECC1 PDIA3 DICER1 ACTR3 RBM39 GFM2 MRPS10 USP10 MYOF UTP18 HLTF LRP4 SLIRP MRPL9 | 8.52e-10 | 1440 | 234 | 33 | 30833792 | |
| Pubmed | DDX47 MTA2 DNAJB11 BCOR ANKRD54 ZNF461 BRCA1 INTS11 USP7 MACROH2A2 TAF4 VCP MRE11 EP400 PHF12 KAT6A ADNP2 BAZ1B DDX56 YTHDC2 MACROH2A1 DICER1 TRMT2A TBK1 EHMT1 LRP4 CEP295 CEP170B | 2.60e-09 | 1116 | 234 | 28 | 31753913 | |
| Pubmed | DAB2IP RTEL1 WNK1 ZNF462 ESYT2 CLCN6 CAMTA1 MED13L DICER1 MYOF SLIT1 EHMT1 HPS5 | 5.04e-09 | 225 | 234 | 13 | 12168954 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MTA2 AASDHPPT PFKM BCOR WNK1 RASSF5 ZC3H11A AHNAK USP7 VCP MRE11 IRS4 EP400 L3MBTL2 ZNF280C BAZ1B YTHDC2 MACROH2A1 PDIA3 RBM39 USP10 PRCC TJP1 SKA3 HERC4 | 5.54e-09 | 934 | 234 | 25 | 33916271 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DDX47 MTA2 DNAJB11 ZC3H11A NF1 AHNAK AFDN BOP1 MACROH2A2 VCP MRE11 IRS4 EP400 BAZ1B DDX56 YTHDC2 MACROH2A1 SPECC1 PDIA3 DICER1 ACTR3 RBM39 TJP1 TBK1 GET3 XPNPEP3 | 7.90e-09 | 1024 | 234 | 26 | 24711643 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BCOR ADARB1 ESYT2 ZC3H11A NF1 USP7 KDM2B AFDN PLCB3 CSTF2T MRE11 EP400 PHF12 MYO18A BAZ1B YTHDC2 PACS1 USP10 MYOF UTP18 WDHD1 CDK13 | 1.67e-08 | 774 | 234 | 22 | 15302935 |
| Pubmed | A2M RAD54L2 ITPR1 AFDN C4A C4B PLCB3 EXOC7 SEMA3C POLE YTHDC2 DICER1 PACS1 TRMT2A PRCC CDK13 TBK1 HLTF PARN HPS5 | 2.12e-08 | 650 | 234 | 20 | 38777146 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MTA2 ZNF174 BCOR ZNF462 BRCA1 USP7 KDM2B BOP1 TAF4 L3MBTL2 PTBP2 PHF12 ZNF280C KAT6A ADNP2 BAZ1B HLTF EHMT1 GATAD1 | 3.80e-08 | 608 | 234 | 19 | 36089195 |
| Pubmed | MTA2 BCOR ZC3H11A AHNAK USP7 KDM2B AFDN TAF4 PLK1 CSTF2T MRE11 IRS4 EP400 BAZ1B USP10 TJP1 TET1 SKA3 | 4.28e-08 | 549 | 234 | 18 | 38280479 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | MTA2 DNAJB11 BCOR ZNF462 GALNT8 USP7 KDM2B FBXO33 L3MBTL2 NOP53 ZNF280C ADNP2 SPECC1 RBM39 TET1 EHMT1 ZNF518B | 5.30e-08 | 495 | 234 | 17 | 27705803 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DDX47 AASDHPPT KLHL20 BRCA1 USP38 USP7 BOP1 PLK1 VCP MRE11 LAMB4 NOP53 VPS4B YTHDC2 DICER1 USP10 UTP18 TRMT2A TJP1 PRIM1 TBK1 GET3 HLTF SLIRP | 9.61e-08 | 1005 | 234 | 24 | 19615732 |
| Pubmed | DDX47 MTA2 ZC3H11A AHNAK USP7 BOP1 TAF4 CSTF2T VCP MRE11 EP400 POLE BAZ1B MACROH2A1 MED13L BROX USP10 WDHD1 CDK13 PRIM1 HLTF EHMT1 PARN SORD | 1.13e-07 | 1014 | 234 | 24 | 32416067 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | A2M DDX47 MTA2 ZC3H11A AHNAK USP7 BOP1 PISD MRE11 SEMA3C DCAF13 NOP53 MYO18A BAZ1B DDX56 YTHDC2 MACROH2A1 SPECC1 ACTR3 RBM39 USP10 MYOF HARS2 UTP18 TJP1 PRIM1 GATAD1 | 1.23e-07 | 1257 | 234 | 27 | 36526897 |
| Pubmed | Interaction network of human early embryonic transcription factors. | RAD54L2 BCOR ZNF462 KDM2B TAF4 EP400 L3MBTL2 PHF12 BAZ1B PDIA3 TBK1 TET1 EHMT1 GATAD1 | 1.36e-07 | 351 | 234 | 14 | 38297188 |
| Pubmed | TEX2 BCOR FRMD4B USP38 KDM2B BOP1 WNK2 EP400 PHF12 ZNF280C DICER1 USP10 TET1 EHMT1 LRP4 HPS5 HERC4 | 1.37e-07 | 529 | 234 | 17 | 14621295 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | DDX47 MTA2 DNAJB11 ITPR1 AHNAK USP7 BOP1 TAF4 VCP DCAF13 NOP53 MYO18A DDX56 MACROH2A1 SPECC1 ACTR3 RBM39 USP10 UTP18 TRMT2A CDK13 TBK1 MRPL9 | 1.39e-07 | 949 | 234 | 23 | 36574265 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | A2M DNAJB11 TRIO TEX2 ITPR1 NF1 BOP1 MACROH2A2 PLCB3 VCP ARHGEF12 YTHDC2 MACROH2A1 RBM39 USP10 SLIT1 | 1.72e-07 | 475 | 234 | 16 | 31040226 |
| Pubmed | DAB2IP DNAJB11 TRIO ZNF174 BCOR ITPR1 ESYT2 AHNAK ARL13B INTS11 USP7 MACROH2A2 FBXO33 PLK1 IRS4 NOP53 ZNF280C PDIA3 ACTR3 PACS1 TJP1 PRIM1 INTS4 FBXW7 | 2.10e-07 | 1049 | 234 | 24 | 27880917 | |
| Pubmed | A2M DDX47 MTA2 USP7 BOP1 MACROH2A2 IRS4 DCAF13 L3MBTL2 NOP53 DDX56 YTHDC2 MACROH2A1 UTP18 CDK13 PARN | 2.15e-07 | 483 | 234 | 16 | 36912080 | |
| Pubmed | DAB2IP DOCK4 DNAJB11 TRIO TEX2 AASDHPPT ITPR1 ESYT2 NF1 USP7 AFDN FHL1 WNK2 VCP DOCK3 SLC4A7 ATP13A1 MYO18A MACROH2A1 SLC1A2 RBM39 TJP1 SFXN3 SLIRP CEP170B | 2.50e-07 | 1139 | 234 | 25 | 36417873 | |
| Pubmed | DDX47 DNAJB11 PFKM EIF2B3 TAF4 PLK1 IRS4 VPS4B TRMT2A PRIM1 TBK1 SFXN3 MRPL9 | 3.46e-07 | 323 | 234 | 13 | 24797263 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 TRIO TEX2 WNK1 NEDD4 ESYT2 NF1 NFATC3 AHNAK AFDN PLK1 IRS4 SLC4A7 ARHGAP17 SPECC1 E2F8 C6orf132 TJP1 TET1 SKA3 CEP170B | 4.51e-07 | 861 | 234 | 21 | 36931259 |
| Pubmed | 5.11e-07 | 103 | 234 | 8 | 32744500 | ||
| Pubmed | 6.35e-07 | 11 | 234 | 4 | 31730000 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 7.04e-07 | 146 | 234 | 9 | 23892456 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | DDX47 MTA2 USP7 BOP1 MACROH2A2 MRE11 DCAF13 NOP53 BAZ1B YTHDC2 ACTR3 USP10 UTP18 | 8.27e-07 | 349 | 234 | 13 | 25665578 |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 8.83e-07 | 150 | 234 | 9 | 28242625 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DDX47 MTA2 ZC3H11A BOP1 MACROH2A2 EXOC7 PLK1 DCAF13 NOP53 POLE KAT6A MYO18A BAZ1B DDX56 YTHDC2 MACROH2A1 USP10 UTP18 CDK13 | 1.11e-06 | 759 | 234 | 19 | 35915203 |
| Pubmed | 1.27e-06 | 116 | 234 | 8 | 30804394 | ||
| Pubmed | MTA2 PFKM ESYT2 CEP120 EIF2B3 AFDN EXOC7 PLK1 IRS4 PTBP2 DDX56 UTP18 TRMT2A HLTF EHMT1 INTS4 | 1.50e-06 | 560 | 234 | 16 | 35241646 | |
| Pubmed | MTA2 ZNF174 JDP2 RAD54L2 PFKM BCOR ZC3H11A BRCA1 TAF4 PLK1 CSTF2T MRE11 EP400 PHF12 AASDH MED13L PDIA3 RBM39 E2F8 CDK13 HLTF EHMT1 SORD | 1.85e-06 | 1103 | 234 | 23 | 34189442 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DDX47 PFKM NF1 AHNAK EXOC7 PLK1 DOCK1 MRE11 PTBP2 POLE YTHDC2 LENG9 RBM39 USP10 PRCC HLTF | 2.46e-06 | 582 | 234 | 16 | 20467437 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DDX47 MTA2 JDP2 BCOR ESYT2 ZC3H11A BRCA1 AHNAK INTS11 USP7 KDM2B TAF4 MRE11 EP400 L3MBTL2 PHF12 BAZ1B DDX56 RBM39 UTP18 CDK13 HLTF EHMT1 GATAD1 INTS4 | 2.51e-06 | 1294 | 234 | 25 | 30804502 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | MTA2 RAD54L2 NFATC3 USP7 TAF4 PLK1 IRS4 EP400 L3MBTL2 PHF12 POLE YTHDC2 RBM39 TRMT2A HLTF EHMT1 | 2.52e-06 | 583 | 234 | 16 | 29844126 |
| Pubmed | DAB2IP TRIO BCOR NEDD4 ZNF462 NF1 NFATC3 ARC AFDN TAF4 WNK2 ARHGEF12 MACROH2A1 SLC1A2 USP10 TJP1 TBK1 SFXN3 EHMT1 PARN CEP170B | 2.66e-06 | 963 | 234 | 21 | 28671696 | |
| Pubmed | RAD54L2 BRCA1 FHL1 PLK1 VCP MRE11 EP400 PHF12 POLE MED13L TRMT2A PRCC SFXN3 PARN | 2.80e-06 | 453 | 234 | 14 | 29656893 | |
| Pubmed | NEDD4 USP7 MACROH2A2 VPS4B BAZ1B YTHDC2 MACROH2A1 BROX USP10 MYOF | 3.74e-06 | 228 | 234 | 10 | 30471916 | |
| Pubmed | Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation. | 3.75e-06 | 134 | 234 | 8 | 28695742 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DDX47 MTA2 ZC3H11A AHNAK USP7 BOP1 PLK1 VCP DCAF13 NOP53 ZNF280C BAZ1B DDX56 MACROH2A1 PDIA3 RBM39 USP10 UTP18 TRMT2A HLTF PARN | 4.01e-06 | 989 | 234 | 21 | 36424410 |
| Pubmed | RAD54L2 BCOR STAT2 ZNF462 BRCA1 NFATC3 USP7 KDM2B TAF4 FHL1 MRE11 IRS4 EP400 L3MBTL2 NOP53 PHF12 MYO18A BAZ1B DDX56 ACTR3 MRPS10 PRCC EHMT1 GATAD1 SORD FBXW7 | 4.60e-06 | 1429 | 234 | 26 | 35140242 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DDX47 MTA2 DNAJB11 ZNF462 INTS11 USP7 MACROH2A2 CSTF2T VCP EP400 PTBP2 MYO18A DDX56 MACROH2A1 RBM39 TJP1 XPNPEP3 SFXN3 EHMT1 INTS4 CATSPERG TNXB | 4.67e-06 | 1082 | 234 | 22 | 38697112 |
| Pubmed | MTA2 TRIO PFKM JMY NF1 CLCN6 USP7 AFDN C4A C4B FHL1 WNK2 VCP MYO18A ARHGEF12 YTHDC2 SPECC1 SLC1A2 PDIA3 ACTR3 RBM39 PACS1 USP10 TJP1 SFXN3 CEP170B | 4.71e-06 | 1431 | 234 | 26 | 37142655 | |
| Pubmed | DAB2IP TEX2 OBSCN BCOR WNK1 ITPR1 ZC3H11A BOP1 CAMTA1 MRE11 SLC4A7 PTBP2 POLG BAZ1B WDFY4 E2F8 PACS1 WDHD1 TET1 SFXN3 CEP295 HERC4 | 4.81e-06 | 1084 | 234 | 22 | 11544199 | |
| Pubmed | MYH7 MYH8 ZNF174 ADAM7 STOX1 RAD54L2 PFKM BRCA1 AHNAK TAF4 ITIH6 ZNF541 RAC3 IRS4 DCAF13 PTBP2 MYO18A MACROH2A1 PDIA3 ACTR3 UTP18 TJP1 CDK13 CSPG4 CEP295 CCDC158 | 5.40e-06 | 1442 | 234 | 26 | 35575683 | |
| Pubmed | 5.68e-06 | 18 | 234 | 4 | 29743367 | ||
| Pubmed | Androgen-dependent hereditary mouse keratoconus: linkage to an MHC region. | 5.92e-06 | 6 | 234 | 3 | 11773012 | |
| Pubmed | 6.12e-06 | 102 | 234 | 7 | 11214970 | ||
| Pubmed | 6.33e-06 | 242 | 234 | 10 | 34011540 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | A2M DDX47 MTA2 PFKM WNK1 ESYT2 ZC3H11A AHNAK AFDN BOP1 FHL1 VCP MRE11 DCAF13 MYO18A MACROH2A1 PDIA3 ACTR3 RBM39 MYOF UTP18 TJP1 GET3 SFXN3 SKA3 | 6.50e-06 | 1367 | 234 | 25 | 32687490 |
| Pubmed | 7.90e-06 | 106 | 234 | 7 | 19394292 | ||
| Pubmed | MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity. | 8.62e-06 | 150 | 234 | 8 | 22678362 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | A2M MYH7 MYH8 ESYT2 AHNAK EXOC7 FHL1 VCP IRS4 NOP53 MYO18A PDIA3 ACTR3 XPNPEP3 SFXN3 SLIRP | 9.31e-06 | 647 | 234 | 16 | 26618866 |
| Pubmed | 9.38e-06 | 72 | 234 | 6 | 33106477 | ||
| Pubmed | ADARB1 ZC3H11A MACROH2A2 CSTF2T VCP DCAF13 PTBP2 NOP53 VPS4B PDIA3 DICER1 USP10 UTP18 CDK13 INTS4 SLIRP FBXW7 | 9.39e-06 | 723 | 234 | 17 | 34133714 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TEX2 DGKH PFKM ITPR1 ESYT2 EIF2B3 BOP1 PLK1 VCP IRS4 SLC4A7 NOP53 POLE POLG DDX56 YTHDC2 MACROH2A1 PDIA3 RBM39 GFM2 MRPS10 HARS2 UTP18 CDK13 SLIRP MRPL9 | 1.03e-05 | 1496 | 234 | 26 | 32877691 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.05e-05 | 203 | 234 | 9 | 22083510 | |
| Pubmed | Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. | 1.09e-05 | 21 | 234 | 4 | 25249183 | |
| Pubmed | 1.10e-05 | 74 | 234 | 6 | 29795351 | ||
| Pubmed | TRIO TEX2 WNK1 FRMD4B STAT2 EXOC7 SLC4A7 EP400 L3MBTL2 ATP13A1 VPS4B ARHGAP17 DICER1 WDHD1 TJP1 CEP295 SKA3 | 1.12e-05 | 733 | 234 | 17 | 34672954 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | MTA2 RAD54L2 BCOR ZC3H11A AHNAK USP7 TAF4 EP400 BAZ1B USP10 PRCC TJP1 VWA5A | 1.13e-05 | 444 | 234 | 13 | 34795231 |
| Pubmed | MYH8 WNK1 PTCHD1 ZC3H11A NF1 USP7 TAF4 PLK1 CCDC140 MRE11 SLC4A7 ATP13A1 PHF12 MED13L DICER1 RBM39 USP10 TRMT2A CDK13 XPNPEP3 GATAD1 PARN SKA3 FBXW7 | 1.21e-05 | 1327 | 234 | 24 | 32694731 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DOCK4 RIOK3 RAD54L2 BCOR WNK1 STAT2 NFATC3 USP7 KDM2B EP400 BAZ1B ARHGAP17 AASDH TBK1 CEP170B | 1.24e-05 | 588 | 234 | 15 | 38580884 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MTA2 MYH7 MYH8 TRIO ANKRD54 RASSF5 NF1 USP7 BOP1 FGFR3 PLK1 DDR1 SPECC1 DICER1 MYOF TRMT2A CDK13 TBK1 PARN | 1.48e-05 | 910 | 234 | 19 | 36736316 |
| Pubmed | Characterization of MRFAP1 turnover and interactions downstream of the NEDD8 pathway. | 1.60e-05 | 23 | 234 | 4 | 22038470 | |
| Pubmed | Molecular genetics of the human MHC complement gene cluster. | 1.64e-05 | 8 | 234 | 3 | 10072631 | |
| Pubmed | DDX47 USP7 BOP1 MACROH2A2 DCAF13 BAZ1B DDX56 YTHDC2 MACROH2A1 UTP18 TJP1 | 1.75e-05 | 332 | 234 | 11 | 25693804 | |
| Pubmed | MTA2 ESYT2 AHNAK USP7 SLC4A7 NOP53 SPECC1 ACTR3 MYOF HARS2 WDHD1 CDK13 | 1.90e-05 | 399 | 234 | 12 | 37536630 | |
| Pubmed | MTA2 ADARB1 USP7 BOP1 PLK1 VCP DDX56 YTHDC2 LENG9 PDIA3 DICER1 RBM39 SLIRP | 2.01e-05 | 469 | 234 | 13 | 37314180 | |
| Pubmed | BCOR ZC3H11A BRCA1 USP7 KDM2B PLK1 IRS4 EP400 L3MBTL2 NOP53 RBM39 | 2.12e-05 | 339 | 234 | 11 | 30415952 | |
| Pubmed | 2.15e-05 | 222 | 234 | 9 | 37071664 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DOCK4 TRIO PFKM ESYT2 CEP120 NFATC3 AFDN FHL1 PLK1 L3MBTL2 PHF12 ACTR3 RBM39 TJP1 PRIM1 TBK1 CEP295 CEP170B | 2.17e-05 | 853 | 234 | 18 | 28718761 |
| Pubmed | NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy. | 2.26e-05 | 25 | 234 | 4 | 30309841 | |
| Pubmed | DAB2IP DOCK4 NEDD4 ZC3H11A ZFR2 CAMTA1 EP400 ARHGEF12 MED13L SLIT1 CEP170B PDZD2 | 2.31e-05 | 407 | 234 | 12 | 12693553 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 2.32e-05 | 125 | 234 | 7 | 32891193 | |
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 2.44e-05 | 85 | 234 | 6 | 16051665 | |
| Pubmed | 2.45e-05 | 9 | 234 | 3 | 30824354 | ||
| Pubmed | 2.45e-05 | 9 | 234 | 3 | 26347747 | ||
| Pubmed | DNAJB11 TEX2 PFKM ITPR1 ESYT2 ARL13B BOP1 VCP DCAF13 SLC4A7 L3MBTL2 ATP13A1 POLE MYO18A BAZ1B MACROH2A1 PDIA3 DICER1 MRPS10 USP10 UTP18 PRCC EHMT1 SLIRP MRPL9 | 2.66e-05 | 1487 | 234 | 25 | 33957083 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF174 BCOR ZC3H11A BRCA1 AHNAK AFDN TAF4 MRE11 IRS4 EP400 PTBP2 NOP53 ZNF280C BAZ1B MACROH2A1 RBM39 PRCC TJP1 PARN | 2.82e-05 | 954 | 234 | 19 | 36373674 |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | MTA2 DNAJB11 ZC3H11A USP7 PHF12 BAZ1B PDIA3 DICER1 UTP18 GATAD1 | 2.93e-05 | 289 | 234 | 10 | 23752268 |
| Pubmed | BCOR ZNF462 AHNAK KDM2B CSTF2T IRS4 L3MBTL2 PHF12 VPS4B TBK1 TET1 SKA3 | 2.99e-05 | 418 | 234 | 12 | 34709266 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DAB2IP STAT2 ESYT2 AHNAK AFDN PLCB3 MRE11 SLC4A7 ARHGEF12 MACROH2A1 SPECC1 C6orf132 TBC1D10A TJP1 | 3.32e-05 | 565 | 234 | 14 | 25468996 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DAB2IP MTA2 AGPAT3 WNK1 NPHP4 NF1 CEP120 AHNAK EIF2B3 AFDN PISD EXOC7 PLK1 FOXJ1 MRE11 PIGS PDIA3 DICER1 ACTR3 PACS1 PRCC TBK1 XPNPEP3 | 3.34e-05 | 1321 | 234 | 23 | 27173435 |
| Pubmed | RTEL1 WNK1 NPHP4 ZNF462 EXOC7 CSTF2T DOCK3 ATP13A1 WDFY4 HIVEP3 MYOF CDK13 ZNF518B | 3.37e-05 | 493 | 234 | 13 | 15368895 | |
| Pubmed | Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy. | 3.48e-05 | 10 | 234 | 3 | 27249321 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | A2M MTA2 DNAJB11 AASDHPPT PFKM ESYT2 EIF2B3 AFDN BOP1 PLK1 VCP SLC27A3 MRE11 POLE YTHDC2 PDIA3 DICER1 TJP1 SFXN3 | 3.73e-05 | 974 | 234 | 19 | 28675297 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | DDX47 ADARB1 ZC3H11A CSTF2T VCP DCAF13 PTBP2 NOP53 MYO18A YTHDC2 RBM39 USP10 HARS2 UTP18 CDK13 SLIRP MRPL9 | 3.77e-05 | 807 | 234 | 17 | 22681889 |
| Pubmed | 3.83e-05 | 92 | 234 | 6 | 37343697 | ||
| Pubmed | DDX47 MTA2 MORN1 ESYT2 FHL1 VCP PTBP2 NOP53 BAZ1B DDX56 PDIA3 RBM39 UTP18 WDHD1 PRCC | 4.14e-05 | 653 | 234 | 15 | 33742100 | |
| Pubmed | 4.16e-05 | 57 | 234 | 5 | 17296600 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | A2M NEDD4 FBLN1 C4A C4B MACROH2A2 ALOX15B VCP RAC3 SEMA3C VPS4B MACROH2A1 ACTR3 BROX MYOF HMCN1 TBC1D10A CSPG4 TNXB SORD | 4.21e-05 | 1070 | 234 | 20 | 23533145 |
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 19062096 | ||
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 4.51e-05 | 2 | 234 | 2 | 17645767 | |
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 12207352 | ||
| Interaction | PFN1 interactions | DOCK4 TRIO TEX2 WNK1 JMY STAT2 NEDD4 RASSF5 ESYT2 NF1 BRCA1 AFDN ZNF541 VCP RAC3 DOCK1 DCAF13 ARHGEF12 ARHGAP17 PDIA3 RBM39 C6orf132 TJP1 | 1.90e-08 | 509 | 228 | 23 | int:PFN1 |
| Interaction | TOP3B interactions | DAB2IP MTA2 MORN1 TRIO RTEL1 OBSCN PSMB10 WNK1 NPHP4 STK11IP ZC3H11A AHNAK EIF2B3 INTS11 USP7 ARC WNK2 DOCK3 PNPLA2 EP400 ATP13A1 PHF12 POLE POLG KAT6A ARHGAP17 DDX56 MACROH2A1 MED13L ATP13A2 ACTR3 C6orf132 HIVEP3 USP10 MYOF CDK13 CSPG4 EHMT1 LRP4 CEP170B | 1.84e-07 | 1470 | 228 | 40 | int:TOP3B |
| Interaction | EED interactions | DDX47 MTA2 DNAJB11 TRIO OBSCN BCOR NEDD4 ZC3H11A BRCA1 USP7 KDM2B AFDN BOP1 MACROH2A2 FHL1 PLK1 UAP1L1 VCP MRE11 DCAF13 EP400 L3MBTL2 ZNF280C MYO18A BAZ1B DDX56 MACROH2A1 NUPR1 ACTR3 RBM39 USP10 UTP18 TJP1 TBK1 GET3 EHMT1 GATAD1 CEP170B | 9.11e-07 | 1445 | 228 | 38 | int:EED |
| Interaction | CGAS interactions | RAD54L2 NEDD4 BRCA1 USP7 MACROH2A2 RAC3 VPS4B ZNF280C BAZ1B YTHDC2 MACROH2A1 NUPR1 DICER1 BROX USP10 MYOF | 1.16e-06 | 329 | 228 | 16 | int:CGAS |
| Interaction | CBX5 interactions | BCOR ADARB1 KLHL20 ZNF462 BRCA1 MACROH2A2 TAF4 L3MBTL2 ZNF280C KAT6A ADNP2 TRIM39 MACROH2A1 NUPR1 EHMT1 ZNF518B | 3.22e-06 | 356 | 228 | 16 | int:CBX5 |
| Interaction | RHOB interactions | DAB2IP DDX47 TRIO DGKH STK11IP ESYT2 NF1 ARL13B AFDN PLK1 VCP DOCK1 IRS4 SLC4A7 MYO18A ARHGEF12 ARHGAP17 DDX56 MACROH2A1 SPECC1 BROX MYOF TBC1D10A TJP1 SFXN3 LRP4 | 3.43e-06 | 840 | 228 | 26 | int:RHOB |
| Interaction | SNRNP40 interactions | BCOR ZNF462 BRCA1 BOP1 TAF4 VCP DDR1 EP400 PTBP2 NOP53 PHF12 ZNF280C KAT6A ADNP2 DDX56 MACROH2A1 AASDH NUPR1 RBM39 PRCC HLTF INTS4 | 3.66e-06 | 637 | 228 | 22 | int:SNRNP40 |
| Interaction | H2BC21 interactions | MTA2 OBSCN BCOR ADARB1 BRCA1 SASH3 AHNAK INTS11 USP7 MACROH2A2 MRE11 EP400 PHF12 ZNF280C KAT6A BAZ1B MACROH2A1 TET1 HLTF EHMT1 GATAD1 ZNF518B FBXW7 | 4.52e-06 | 696 | 228 | 23 | int:H2BC21 |
| Interaction | NUMA1 interactions | DNAJB11 ADARB1 BRCA1 USP7 MACROH2A2 VCP MRE11 DCAF13 TEDC2 VPS4B ZNF280C KAT6A BAZ1B MACROH2A1 NUPR1 RBM39 EHMT1 FBXW7 | 7.06e-06 | 469 | 228 | 18 | int:NUMA1 |
| Interaction | PLEC interactions | WNK1 NPHP4 ADARB1 ITPR1 BRCA1 AHNAK FES USP7 VCP TEDC2 MYO18A NUPR1 WDFY4 PDIA3 AXDND1 TJP1 FBXW7 | 8.70e-06 | 430 | 228 | 17 | int:PLEC |
| Interaction | ELK3 interactions | 9.13e-06 | 120 | 228 | 9 | int:ELK3 | |
| Interaction | MYH9 interactions | MTA2 TEX2 PSMB10 WNK1 NPHP4 ADARB1 JMY BRCA1 AHNAK USP7 BOP1 VCP TEDC2 MYO18A MACROH2A1 NUPR1 SPECC1 ATP13A2 WDFY4 ACTR3 SORD FBXW7 MYBPC3 | 1.64e-05 | 754 | 228 | 23 | int:MYH9 |
| Interaction | USP36 interactions | A2M DDX47 MTA2 DOCK4 ADARB1 NEDD4 USP7 BOP1 MACROH2A2 IRS4 DCAF13 L3MBTL2 NOP53 DDX56 YTHDC2 MACROH2A1 UTP18 CDK13 PARN FBXW7 | 1.68e-05 | 599 | 228 | 20 | int:USP36 |
| Interaction | RPL7L1 interactions | ADARB1 BOP1 MACROH2A2 CCDC140 VCP NOP53 KAT6A BAZ1B DDX56 YTHDC2 MRPS10 | 2.09e-05 | 203 | 228 | 11 | int:RPL7L1 |
| Interaction | SMARCA4 interactions | MTA2 STK11IP ADARB1 STAT2 NF1 BRCA1 USP7 VCP EP400 L3MBTL2 KAT6A MYO18A BAZ1B MACROH2A1 PDIA3 ACTR3 FBXW7 | 2.19e-05 | 462 | 228 | 17 | int:SMARCA4 |
| Interaction | TOP2A interactions | MTA2 ADARB1 KLHL20 CKMT2 NF1 BRCA1 USP7 MACROH2A2 PLK1 MRE11 POLE KAT6A BAZ1B MACROH2A1 NUPR1 RBM39 PRIM1 FBXW7 | 2.81e-05 | 520 | 228 | 18 | int:TOP2A |
| Interaction | NUP43 interactions | MTA2 RAD54L2 BCOR ZNF462 BRCA1 BOP1 TAF4 EP400 L3MBTL2 NOP53 PHF12 ZNF280C MACROH2A1 NUPR1 RBM39 HLTF EHMT1 PARN HPS5 PDZD2 | 3.08e-05 | 625 | 228 | 20 | int:NUP43 |
| Interaction | SDC2 interactions | 3.72e-05 | 143 | 228 | 9 | int:SDC2 | |
| Interaction | FLII interactions | MTA2 PSMB10 BRCA1 EIF2B3 VCP MRE11 TEDC2 MYO18A NUPR1 ACTR3 WDHD1 HERC4 FBXW7 | 3.73e-05 | 298 | 228 | 13 | int:FLII |
| Interaction | CDC42 interactions | A2M DDX47 TRIO RIOK3 PFKM WNK1 STK11IP ITPR1 ESYT2 NF1 AHNAK EIF2B3 ARL13B AFDN VCP RAC3 IRS4 SLC4A7 PIGS MYO18A ARHGEF12 ARHGAP17 DDX56 MACROH2A1 NUPR1 SPECC1 ACTR3 RBM39 MYOF TJP1 CSPG4 SFXN3 | 3.89e-05 | 1323 | 228 | 32 | int:CDC42 |
| Interaction | POU5F1 interactions | DDX47 MTA2 NEDD4 ZNF462 AHNAK USP7 KDM2B AFDN PLK1 MRE11 EP400 L3MBTL2 PTBP2 SPECC1 ACTR3 MRPS10 TET1 HLTF MRPL9 | 3.91e-05 | 584 | 228 | 19 | int:POU5F1 |
| Interaction | SIRT7 interactions | MTA2 ZC3H11A NF1 AHNAK USP7 AFDN BOP1 VCP MRE11 IRS4 DCAF13 NOP53 POLE BAZ1B DDX56 YTHDC2 DICER1 ACTR3 RBM39 UTP18 TJP1 PARN | 4.04e-05 | 744 | 228 | 22 | int:SIRT7 |
| Interaction | SUMO2 interactions | MTA2 RAD54L2 PFKM NEDD4 ZC3H11A BRCA1 AHNAK USP7 ARC VCP MRE11 EP400 BAZ1B NUPR1 PDIA3 WDHD1 TBK1 EHMT1 PARN | 4.59e-05 | 591 | 228 | 19 | int:SUMO2 |
| Interaction | H3-4 interactions | MTA2 PSMB10 AHNAK TAF4 DOCK3 MRE11 L3MBTL2 PHF12 KAT6A MACROH2A1 THSD7B RBM39 CDK13 EHMT1 GATAD1 CXCL8 | 5.47e-05 | 448 | 228 | 16 | int:H3-4 |
| Interaction | KLF12 interactions | BCOR USP7 KDM2B EP400 L3MBTL2 PHF12 DDX56 MRPS10 EHMT1 GATAD1 | 7.57e-05 | 194 | 228 | 10 | int:KLF12 |
| Interaction | RHOF interactions | DDX47 ADAM7 SLCO3A1 PFKM ESYT2 ARL13B PLCB3 VCP IRS4 SLC4A7 PIGS VPS4B DDX56 SPECC1 PACS1 MYOF UTP18 TJP1 SFXN3 HLTF | 8.55e-05 | 673 | 228 | 20 | int:RHOF |
| Interaction | SMC1A interactions | DDX47 MTA2 ZNF174 ADARB1 KLHL20 BRCA1 MACROH2A2 FGFR3 PLK1 WNK2 MRE11 L3MBTL2 POLE HLTF FBXW7 | 8.88e-05 | 418 | 228 | 15 | int:SMC1A |
| Interaction | GRIN2D interactions | 9.54e-05 | 41 | 228 | 5 | int:GRIN2D | |
| Interaction | KLF8 interactions | BCOR NEDD4 KDM2B TAF4 IRS4 EP400 L3MBTL2 NOP53 PHF12 BAZ1B DDX56 EHMT1 GATAD1 | 1.02e-04 | 329 | 228 | 13 | int:KLF8 |
| Interaction | SIRT6 interactions | DDX47 MTA2 PI4K2B MYH7 BCOR ITPR1 NF1 USP7 BOP1 IRS4 EP400 DDX56 YTHDC2 MACROH2A1 DICER1 RBM39 USP10 WDHD1 EHMT1 | 1.02e-04 | 628 | 228 | 19 | int:SIRT6 |
| Interaction | CIAO1 interactions | RTEL1 RASSF5 VCP MRE11 DCAF13 SLC4A7 POLE ZNF280C DDX56 TJP1 PRIM1 MRPL9 | 1.18e-04 | 289 | 228 | 12 | int:CIAO1 |
| Interaction | KLF15 interactions | BCOR KDM2B TAF4 IRS4 EP400 L3MBTL2 NOP53 PHF12 DDX56 EHMT1 GATAD1 ZNF518B | 1.22e-04 | 290 | 228 | 12 | int:KLF15 |
| Interaction | NANOG interactions | MTA2 BCOR ZNF462 BRCA1 USP7 KDM2B MRE11 EP400 L3MBTL2 SPECC1 TET1 HLTF EHMT1 INTS4 MRPL9 FBXW7 | 1.25e-04 | 481 | 228 | 16 | int:NANOG |
| Interaction | NAA40 interactions | MTA2 AASDHPPT PFKM BCOR WNK1 RASSF5 ZC3H11A AHNAK USP7 VCP MRE11 IRS4 EP400 L3MBTL2 ZNF280C BAZ1B YTHDC2 MACROH2A1 PDIA3 RBM39 USP10 PRCC TJP1 SKA3 HERC4 | 1.25e-04 | 978 | 228 | 25 | int:NAA40 |
| Interaction | DNAJA2 interactions | PI4K2B BRCA1 PISD VCP IRS4 DCAF13 L3MBTL2 TEDC2 PIGS POLG NUPR1 ACTR3 TRMT2A TBK1 SFXN3 HPS5 FBXW7 | 1.56e-04 | 542 | 228 | 17 | int:DNAJA2 |
| Interaction | RCOR1 interactions | MTA2 ZNF174 BCOR AHNAK KDM2B CSTF2T VCP IRS4 L3MBTL2 PHF12 VPS4B MACROH2A1 WDHD1 TET1 EHMT1 FBXW7 | 1.69e-04 | 494 | 228 | 16 | int:RCOR1 |
| Interaction | ZFR interactions | BCOR ADARB1 BRCA1 USP7 VCP KAT6A NUPR1 RBM39 AXDND1 SKA3 SLIRP FBXW7 | 1.73e-04 | 301 | 228 | 12 | int:ZFR |
| Interaction | KDM1A interactions | MTA2 BCOR ADARB1 ZNF462 BRCA1 USP38 AHNAK USP7 KDM2B EXOC7 CSTF2T IRS4 EP400 PHF12 TEDC2 VPS4B ZNF280C TRIM39 RBM39 TBK1 TET1 EHMT1 SKA3 FBXW7 | 1.78e-04 | 941 | 228 | 24 | int:KDM1A |
| Interaction | U2SURP interactions | PSMB10 ADARB1 TAF4 CSTF2T TEDC2 MYO18A MACROH2A1 NUPR1 ACTR3 RBM39 USP10 TBK1 SKA3 | 1.82e-04 | 349 | 228 | 13 | int:U2SURP |
| Interaction | RAC1 interactions | DAB2IP DOCK4 TRIO SLCO3A1 PFKM NEDD4 ESYT2 NF1 ARL13B PLCB3 VCP RAC3 DOCK1 DOCK3 IRS4 SLC4A7 ATP13A1 MYO18A ARHGAP17 DDX56 SPECC1 RBM39 PACS1 MYOF TLR2 LRP4 | 1.84e-04 | 1063 | 228 | 26 | int:RAC1 |
| Interaction | IFI16 interactions | DDX47 DNAJB11 OBSCN BRCA1 USP7 BOP1 MACROH2A2 TAF4 DCAF13 NOP53 BAZ1B DDX56 YTHDC2 MACROH2A1 ACTR3 RBM39 USP10 UTP18 TJP1 FBXW7 | 1.88e-04 | 714 | 228 | 20 | int:IFI16 |
| Interaction | RPA4 interactions | AASDHPPT PFKM BRCA1 AHNAK AFDN FHL1 VCP MRE11 IRS4 PIGS MACROH2A1 PRCC TJP1 CDK13 SKA3 | 2.09e-04 | 452 | 228 | 15 | int:RPA4 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.56e-05 | 161 | 163 | 9 | 593 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 5.81e-05 | 9 | 163 | 3 | 1234 | |
| GeneFamily | PDZ domain containing | 4.61e-04 | 152 | 163 | 7 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 6.26e-04 | 160 | 163 | 7 | 555 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 7.94e-04 | 5 | 163 | 2 | 1336 | |
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 7.94e-04 | 5 | 163 | 2 | 1213 | |
| GeneFamily | Fibulins | 2.18e-03 | 8 | 163 | 2 | 556 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 TRIO ADARB1 KLHL20 ITPR1 NEDD4 BRCA1 NFATC3 USP7 TAF4 SLC27A3 DOCK1 SEMA3C SLC4A7 KAT6A BAZ1B MED13L DICER1 RBM39 MYOF UTP18 WDHD1 CDK13 HLTF PARN HERC4 | 4.99e-08 | 856 | 232 | 26 | M4500 |
| Coexpression | GSE24574_NAIVE_VS_TCONV_CD4_TCELL_DN | 1.26e-05 | 200 | 232 | 10 | M8330 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | PF4 IL18RAP TTPA NEDD4 BRCA1 PLK1 DOCK1 POLE E2F8 WDHD1 HMCN1 TJP1 PRIM1 TET1 SKA3 SORD | 1.39e-05 | 423 | 227 | 16 | GSM791126_500 |
| ToppCell | Epithelial-Epithelial-B_(AT1-AT2-progenitors)|Epithelial / shred on cell class and cell subclass (v4) | PI4K2B ZNF174 TIGD4 WNK1 ITPR1 VSTM4 CKMT2 AHNAK DOCK3 AXDND1 | 9.15e-09 | 154 | 233 | 10 | 770712806e26f73456fb77a81aa4ef8ec78a21ea |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | AGPAT4 ADARB1 VSTM4 BRCA1 FHL1 CACNA1D HIVEP3 WDHD1 PRIM1 ST8SIA2 | 3.27e-08 | 176 | 233 | 10 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGEF38 SLCO3A1 DGKH RYR3 LAMB4 SLC4A7 CASR SLC1A2 MYOF TLR2 | 6.41e-08 | 189 | 233 | 10 | e059be2965cca70ff5576df055d0af1775b76e00 |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | DOCK4 ADARB1 NEDD4 VSTM4 FGFR3 FHL1 CACNA1D HIVEP3 HMCN1 ST8SIA2 | 6.41e-08 | 189 | 233 | 10 | dc5164591dea45b420798b94dda211be03daa70c |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | A2M DOCK4 ADARB1 FRMD4B VSTM4 AFDN FHL1 CACNA1D HIVEP3 HMCN1 | 9.01e-08 | 196 | 233 | 10 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | A2M DOCK4 ADARB1 FRMD4B VSTM4 AFDN FHL1 CACNA1D HIVEP3 HMCN1 | 9.01e-08 | 196 | 233 | 10 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-07 | 160 | 233 | 9 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.53e-07 | 167 | 233 | 9 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.94e-07 | 170 | 233 | 9 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.46e-07 | 183 | 233 | 9 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Fibroblast-A|World / shred on cell class and cell subclass (v4) | 6.84e-07 | 188 | 233 | 9 | 6740bed5fb8f45b6eea17041894b804214c2a4ae | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.16e-07 | 189 | 233 | 9 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-07 | 191 | 233 | 9 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-07 | 191 | 233 | 9 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.81e-07 | 191 | 233 | 9 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-07 | 191 | 233 | 9 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-07 | 191 | 233 | 9 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.52e-07 | 193 | 233 | 9 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.52e-07 | 193 | 233 | 9 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.52e-07 | 193 | 233 | 9 | 1b2cc627b2aa002b442358bd1188d470e67ce7d9 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.28e-07 | 195 | 233 | 9 | cbe518b465b4ef32797ae6b608219207c08493df | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.28e-07 | 195 | 233 | 9 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.28e-07 | 195 | 233 | 9 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.28e-07 | 195 | 233 | 9 | 2f9a274b26fc528a85f50933ec2f4db1dc9da0ca | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.28e-07 | 195 | 233 | 9 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.28e-07 | 195 | 233 | 9 | 136b06b0931a69b1241101f68c01c44c70365fd9 | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.42e-07 | 144 | 233 | 8 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.69e-07 | 196 | 233 | 9 | 14246f00c90741a5f8683f377e22e3a7c99661b9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-07 | 196 | 233 | 9 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-07 | 196 | 233 | 9 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.69e-07 | 196 | 233 | 9 | 2a885eed52f9b002c7995e11e450c7e8d7ae69e6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-06 | 197 | 233 | 9 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.15e-06 | 200 | 233 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 162 | 233 | 8 | 593939be9d38690c89c31d4c58e351de26cbf9ab | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 162 | 233 | 8 | 3a61eda548afa2a41bdf6293d1050103dc210e52 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.27e-06 | 170 | 233 | 8 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.69e-06 | 122 | 233 | 7 | 37612ad087d9c11d4a3466244ab36224de31930b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-06 | 123 | 233 | 7 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.59e-06 | 178 | 233 | 8 | 09475e522dc1b8cf9ff1c25de5d1e3082b162948 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.59e-06 | 178 | 233 | 8 | 000d25f3f13cc76cf39c46c312c6fafc2ea4f368 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.59e-06 | 178 | 233 | 8 | 35de8f791b0e78a6caf52ff095f05e204a59e828 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-06 | 180 | 233 | 8 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-06 | 180 | 233 | 8 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-06 | 180 | 233 | 8 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-06 | 181 | 233 | 8 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-06 | 181 | 233 | 8 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.34e-06 | 129 | 233 | 7 | 13cd10ffdd8f1ef7721884e9efd2cf25f170f414 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-06 | 182 | 233 | 8 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 5.86e-06 | 184 | 233 | 8 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.10e-06 | 185 | 233 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-06 | 187 | 233 | 8 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-06 | 187 | 233 | 8 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-06 | 187 | 233 | 8 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 6.60e-06 | 187 | 233 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-06 | 189 | 233 | 8 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-06 | 189 | 233 | 8 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-06 | 189 | 233 | 8 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.13e-06 | 189 | 233 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.41e-06 | 190 | 233 | 8 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.41e-06 | 190 | 233 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 7.41e-06 | 190 | 233 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.41e-06 | 190 | 233 | 8 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.70e-06 | 191 | 233 | 8 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.70e-06 | 191 | 233 | 8 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.70e-06 | 191 | 233 | 8 | b5210de890d338602857b5907135705a507bc2b0 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.70e-06 | 191 | 233 | 8 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.70e-06 | 191 | 233 | 8 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.70e-06 | 191 | 233 | 8 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | 7.70e-06 | 191 | 233 | 8 | 37cf121e6e80760c8519075b7845b9029958a988 | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.70e-06 | 191 | 233 | 8 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.70e-06 | 191 | 233 | 8 | d4f535b06ad483448ab692e9900c872c78cbed60 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.31e-06 | 193 | 233 | 8 | 8d05805295c5d3aa93aeb38be5fbefa81e1be1f0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.31e-06 | 193 | 233 | 8 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.31e-06 | 193 | 233 | 8 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 8.31e-06 | 193 | 233 | 8 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.63e-06 | 194 | 233 | 8 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.96e-06 | 195 | 233 | 8 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.96e-06 | 195 | 233 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.96e-06 | 195 | 233 | 8 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.96e-06 | 195 | 233 | 8 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.96e-06 | 195 | 233 | 8 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.30e-06 | 196 | 233 | 8 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.30e-06 | 196 | 233 | 8 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.30e-06 | 196 | 233 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 9.30e-06 | 196 | 233 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 9.65e-06 | 197 | 233 | 8 | 44f37a98f07c3e46a7e8fd3b64c2b2b44d5bbe40 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 198 | 233 | 8 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.00e-05 | 198 | 233 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 198 | 233 | 8 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-early|World / Primary Cells by Cluster | 1.04e-05 | 199 | 233 | 8 | 549391e7a4285da1c0e366654530bcf1cd33fbae | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-05 | 199 | 233 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 199 | 233 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | (2)_Fibroblasts-(24)_Fibro-5|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.04e-05 | 199 | 233 | 8 | 6c0354f57883330c685a8d9d5d3014ace7eca584 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-early-40|World / Primary Cells by Cluster | 1.04e-05 | 199 | 233 | 8 | 23625d757173bdd35a51c7919ff4b588168d2553 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 200 | 233 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Sigmoid-(1)_T_cell-(18)_cycling_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 1.08e-05 | 200 | 233 | 8 | 6e367abd1a4b87e20eb9095b8337723163e8bbae | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|Sigmoid / Region, Cell class and subclass | 1.08e-05 | 200 | 233 | 8 | 9769185abae084ffac36420c749625e679b70ca8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.08e-05 | 200 | 233 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 200 | 233 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 200 | 233 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A | A2M MTA2 MORN1 TRIO FBLN1 ARC EXOC7 FHL1 NUPR1 PACS1 CDK13 TLR2 | 8.63e-07 | 196 | 232 | 12 | 5253_UP |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | ZNF174 ADARB1 KLHL20 NF1 CSTF2T SLC4A7 POLG BAZ1B YTHDC2 MYOF WDHD1 HERC4 | 9.61e-07 | 198 | 232 | 12 | 4733_DN |
| Drug | Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | TRIO AGPAT3 PSMB10 KLHL20 PLCB3 EXOC7 ARHGEF12 ATP13A2 ATP10D HIVEP3 MYOF PDZD2 | 9.61e-07 | 198 | 232 | 12 | 5829_DN |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | MTA2 TRIO SLCO3A1 RAD54L2 WNK1 ITPR1 EXOC7 FHL1 BAZ1B ATP10D TLR2 | 6.03e-06 | 197 | 232 | 11 | 3934_DN |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | WNK1 ADCY1 ITPR1 CLCN6 EXOC7 UAP1L1 CSTF2T PNPLA2 ATP13A2 CDK13 SFXN3 | 6.03e-06 | 197 | 232 | 11 | 2307_DN |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | RTEL1 ADAM7 ARHGEF38 FBLN1 CLCN6 ARC AFDN EXOC7 MACROH2A1 MYOF VWA5A | 6.03e-06 | 197 | 232 | 11 | 5478_UP |
| Drug | Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A | BCOR PLCB3 EXOC7 CACNA1D PTBP2 MYOF TRMT2A WDHD1 VWA5A CDK13 FBXW7 | 6.33e-06 | 198 | 232 | 11 | 2305_DN |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | ST7L STAT2 CLCN6 ABCC8 AHNAK ARC EXOC7 ALOX15B SLC1A2 HDC PDZD2 | 6.33e-06 | 198 | 232 | 11 | 2269_UP |
| Drug | 4-epidoxorubicin | MTA2 MYH7 MYH8 TTPA STAT2 CKMT2 BRCA1 ASB5 USP7 MACROH2A2 PLK1 SLC4A7 POLE POLG MYO18A ARHGEF12 MACROH2A1 CYTIP CSPG4 PODN CEP170B CXCL8 FBXW7 | 6.38e-06 | 788 | 232 | 23 | CID000001690 |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | RTEL1 ADAM7 AFDN EXOC7 CACNA1D LAMB4 SLC4A7 ARHGEF12 EDA ATP10D MYBPC3 | 6.64e-06 | 199 | 232 | 11 | 3205_UP |
| Drug | DB07586 | 1.05e-05 | 74 | 232 | 7 | CID005287979 | |
| Drug | lanthanum | 1.11e-05 | 136 | 232 | 9 | CID000023926 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 2.12e-05 | 185 | 232 | 10 | 6965_DN | |
| Drug | Af1 Neuropeptide | 2.25e-05 | 17 | 232 | 4 | CID000164289 | |
| Drug | COMDP | 2.25e-05 | 17 | 232 | 4 | CID000072268 | |
| Drug | 0297417-0002B [362658-29-5]; Up 200; 10uM; PC3; HT_HG-U133A | 2.55e-05 | 189 | 232 | 10 | 6895_UP | |
| Drug | Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.67e-05 | 190 | 232 | 10 | 4421_DN | |
| Drug | Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | ADARB1 ITPR1 CLCN6 NFATC3 KAT6A NUPR1 HIVEP3 VWA5A CDK13 TLR2 | 2.79e-05 | 191 | 232 | 10 | 6776_UP |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 2.92e-05 | 192 | 232 | 10 | 3400_DN | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; MCF7; HT_HG-U133A | KLHL20 FBLN1 CLCN6 FGFR3 FHL1 CDON CACNA1D HIVEP3 TLR2 EHMT1 | 3.19e-05 | 194 | 232 | 10 | 3968_DN |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; PC3; HG-U133A | 3.33e-05 | 195 | 232 | 10 | 1932_DN | |
| Drug | Cisapride [81098-60-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | NF1 PLCB3 EXOC7 FHL1 DCAF13 ATP13A2 PACS1 GPATCH3 CDK13 CXCL8 | 3.33e-05 | 195 | 232 | 10 | 5305_UP |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | ZNF174 NF1 AHNAK MACROH2A2 FGFR3 EXOC7 SEMA3C SLC4A7 TEDC2 SFXN3 | 3.33e-05 | 195 | 232 | 10 | 6971_DN |
| Drug | Nifenazone [2139-47-1]; Up 200; 13uM; PC3; HT_HG-U133A | 3.48e-05 | 196 | 232 | 10 | 7314_UP | |
| Drug | SC-560; Up 200; 10uM; PC3; HT_HG-U133A | 3.48e-05 | 196 | 232 | 10 | 6865_UP | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 3.48e-05 | 196 | 232 | 10 | 4406_UP | |
| Drug | Dequalinium dichloride [522-51-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A | RAD54L2 ADCY1 NF1 EXOC7 DOCK1 PNPLA2 BAZ1B ATP13A2 PACS1 CEP170B | 3.48e-05 | 196 | 232 | 10 | 5396_DN |
| Drug | Antimycin A [1397-94-0]; Up 200; 7.2uM; HL60; HG-U133A | AGPAT3 GPR63 FBLN1 CLCN6 PLCB3 ARHGEF12 EDA HIVEP3 XPNPEP3 CEP170B | 3.48e-05 | 196 | 232 | 10 | 1414_UP |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 3.48e-05 | 196 | 232 | 10 | 5232_UP | |
| Drug | Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; PC3; HT_HG-U133A | 3.48e-05 | 196 | 232 | 10 | 7300_UP | |
| Drug | Butoconazole nitrate [32872-77-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A | MORN1 ZNF174 STAT2 FBLN1 PLCB3 FHL1 DOCK3 SLC4A7 NUPR1 CXCL8 | 3.48e-05 | 196 | 232 | 10 | 5388_UP |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | RAD54L2 AFDN FHL1 CSTF2T PNPLA2 BAZ1B ATP13A2 TRMT2A XPNPEP3 MYBPC3 | 3.64e-05 | 197 | 232 | 10 | 6241_UP |
| Drug | Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A | RAD54L2 ADARB1 ARC FHL1 PNPLA2 KAT6A ARHGEF12 BAZ1B HIVEP3 EHMT1 | 3.64e-05 | 197 | 232 | 10 | 2235_DN |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Up 200; 6uM; MCF7; HT_HG-U133A | 3.64e-05 | 197 | 232 | 10 | 2819_UP | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A | NFATC3 CSTF2T EP400 BAZ1B MACROH2A1 MYOF TRMT2A GPATCH3 CDK13 FBXW7 | 3.64e-05 | 197 | 232 | 10 | 7186_DN |
| Drug | Lansoprazole [103577-45-3]; Down 200; 10.8uM; PC3; HT_HG-U133A | RTEL1 ZNF174 BCOR NEDD4 FBLN1 FHL1 PNPLA2 YTHDC2 MYOF XPNPEP3 | 3.64e-05 | 197 | 232 | 10 | 7306_DN |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; PC3; HT_HG-U133A | 3.64e-05 | 197 | 232 | 10 | 4545_UP | |
| Drug | Ifosfamide [3778-73-2]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 3.64e-05 | 197 | 232 | 10 | 6279_UP | |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; PC3; HT_HG-U133A | RTEL1 AGPAT3 FBLN1 BRCA1 FHL1 UAP1L1 CSTF2T RAC3 SEMA3C POLG | 3.79e-05 | 198 | 232 | 10 | 1824_DN |
| Drug | Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.79e-05 | 198 | 232 | 10 | 2273_UP | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 3.79e-05 | 198 | 232 | 10 | 2791_UP | |
| Drug | Droperidol [548-73-2]; Up 200; 10.6uM; HL60; HT_HG-U133A | IL18RAP KLHL20 NFATC3 UAP1L1 TEDC2 ARHGEF12 BAZ1B GPATCH3 SLC38A6 CXCL8 | 3.96e-05 | 199 | 232 | 10 | 1290_UP |
| Drug | Gliquidone [33342-05-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 3.96e-05 | 199 | 232 | 10 | 6004_UP | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; HL60; HT_HG-U133A | 3.96e-05 | 199 | 232 | 10 | 2579_UP | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.96e-05 | 199 | 232 | 10 | 2302_UP | |
| Drug | clozapine; Up 200; 10uM; PC3; HT_HG-U133A | 3.96e-05 | 199 | 232 | 10 | 1229_UP | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A_EA | RAD54L2 BRCA1 PLCB3 FGFR3 RAC3 DOCK1 CACNA1D YTHDC2 E2F8 HERC4 | 4.13e-05 | 200 | 232 | 10 | 995_DN |
| Drug | 5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA | 1.23e-04 | 185 | 232 | 9 | 944_UP | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.39e-04 | 188 | 232 | 9 | 4405_UP | |
| Drug | pyrophosphate | MYH7 MYH8 AGPAT4 AASDHPPT PFKM ADCY1 CKMT2 NF1 AFDN PLCB3 TAF4 UAP1L1 POLE POLG MYO18A HARS2 PRIM1 LRP4 | 1.40e-04 | 654 | 232 | 18 | CID000001023 |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.45e-04 | 189 | 232 | 9 | 3788_DN | |
| Drug | AC1N9ZZC | 1.50e-04 | 149 | 232 | 8 | CID004369374 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.57e-04 | 191 | 232 | 9 | 4168_DN | |
| Drug | ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 1.57e-04 | 191 | 232 | 9 | 5964_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 1.63e-04 | 192 | 232 | 9 | 5509_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.63e-04 | 192 | 232 | 9 | 3332_UP | |
| Drug | N-acetylcysteine | MTA2 PFKM ITPR1 CKMT2 USP7 PISD TAF4 ALOX15B MYO18A SLC1A2 PDIA3 CYTIP SLC38A6 CXCL8 SORD FBXW7 | 1.63e-04 | 546 | 232 | 16 | CID000000581 |
| Drug | Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.70e-04 | 193 | 232 | 9 | 3250_UP | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.70e-04 | 193 | 232 | 9 | 3667_DN | |
| Drug | Calycanthine [595-05-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.70e-04 | 193 | 232 | 9 | 2764_UP | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.77e-04 | 194 | 232 | 9 | 3910_DN | |
| Drug | Prednicarbate [73771-04-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.77e-04 | 194 | 232 | 9 | 5544_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 1.77e-04 | 194 | 232 | 9 | 2221_DN | |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.77e-04 | 194 | 232 | 9 | 4163_DN | |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 1.77e-04 | 194 | 232 | 9 | 4178_DN | |
| Drug | Iopanoic acid [96-83-3]; Down 200; 7uM; MCF7; HT_HG-U133A | 1.77e-04 | 194 | 232 | 9 | 3527_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.77e-04 | 194 | 232 | 9 | 2106_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.83e-04 | 195 | 232 | 9 | 2805_UP | |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; HL60; HT_HG-U133A | 1.83e-04 | 195 | 232 | 9 | 2355_DN | |
| Drug | Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.83e-04 | 195 | 232 | 9 | 2852_DN | |
| Drug | Glycopyrrolate [596-51-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.83e-04 | 195 | 232 | 9 | 3427_UP | |
| Drug | lindane | 1.88e-04 | 154 | 232 | 8 | CID000000727 | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.91e-04 | 196 | 232 | 9 | 2329_DN | |
| Drug | felodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.91e-04 | 196 | 232 | 9 | 848_DN | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; PC3; HT_HG-U133A | 1.91e-04 | 196 | 232 | 9 | 7317_DN | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.91e-04 | 196 | 232 | 9 | 4987_DN | |
| Drug | Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; HL60; HT_HG-U133A | 1.91e-04 | 196 | 232 | 9 | 2373_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.91e-04 | 196 | 232 | 9 | 1662_DN | |
| Drug | Methyldopa (L,-) [555-30-6]; Up 200; 19uM; MCF7; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 5637_UP | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 3351_UP | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; PC3; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 6683_UP | |
| Drug | Deoxycorticosterone [64-85-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 5357_UP | |
| Drug | Isocarboxazid [59-63-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 7383_DN | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 5226_DN | |
| Drug | Ofloxacin [82419-36-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 2302_DN | |
| Drug | Procainamide hydrochloride [614-39-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 2618_UP | |
| Drug | Melatonin [73-31-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 3293_UP | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 3616_UP | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; PC3; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 7138_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 2324_DN | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 3813_UP | |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 4974_DN | |
| Drug | Conessine [546-06-5]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 2792_UP | |
| Drug | Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.98e-04 | 197 | 232 | 9 | 3189_DN | |
| Drug | Methylatropine nitrate [52-88-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.06e-04 | 198 | 232 | 9 | 6495_UP | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.06e-04 | 198 | 232 | 9 | 6497_DN | |
| Drug | Cyproterone acetate [427-51-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.06e-04 | 198 | 232 | 9 | 6806_UP | |
| Drug | Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.06e-04 | 198 | 232 | 9 | 5545_DN | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; PC3; HT_HG-U133A | 2.06e-04 | 198 | 232 | 9 | 7268_UP | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; HL60; HG-U133A | 2.06e-04 | 198 | 232 | 9 | 1983_UP | |
| Disease | beta-defensin 119 measurement | 2.29e-05 | 8 | 222 | 3 | EFO_0801419 | |
| Disease | intraocular pressure measurement | ST7L NEDD4 SEMA3C PNPLA2 C6orf89 ARHGEF12 ATP13A2 EDA HIVEP3 MYOF CSPG4 LRP4 TNXB MYBPC3 | 3.52e-05 | 509 | 222 | 14 | EFO_0004695 |
| Disease | Eye Infections, Bacterial | 5.64e-05 | 2 | 222 | 2 | C0015404 | |
| Disease | stomach carcinoma (is_implicated_in) | 8.79e-05 | 12 | 222 | 3 | DOID:5517 (is_implicated_in) | |
| Disease | Keratitis | 1.68e-04 | 3 | 222 | 2 | C0022568 | |
| Disease | N-acetylmethionine measurement | 1.79e-04 | 15 | 222 | 3 | EFO_0021427 | |
| Disease | glycerate measurement | 1.79e-04 | 15 | 222 | 3 | EFO_0021029 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 2.64e-04 | 17 | 222 | 3 | DOID:8677 (biomarker_via_orthology) | |
| Disease | urinary bladder cancer (is_implicated_in) | 2.76e-04 | 76 | 222 | 5 | DOID:11054 (is_implicated_in) | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 3.06e-04 | 43 | 222 | 4 | DOID:9074 (implicated_via_orthology) | |
| Disease | colorectal cancer (is_implicated_in) | 3.17e-04 | 121 | 222 | 6 | DOID:9256 (is_implicated_in) | |
| Disease | Timothy syndrome (implicated_via_orthology) | 3.35e-04 | 4 | 222 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | bacterial pneumonia (implicated_via_orthology) | 3.35e-04 | 4 | 222 | 2 | DOID:874 (implicated_via_orthology) | |
| Disease | liver cancer (implicated_via_orthology) | 3.35e-04 | 4 | 222 | 2 | DOID:3571 (implicated_via_orthology) | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 3.72e-04 | 19 | 222 | 3 | DOID:11198 (implicated_via_orthology) | |
| Disease | Schizophrenia | PI4K2B DOCK4 CMYA5 ADARB1 BRCA1 ARC KDM2B CACNA1F DDR1 ADNP2 SLC1A2 DICER1 TRMT2A TET1 TLR2 ST8SIA2 TNXB | 4.05e-04 | 883 | 222 | 17 | C0036341 |
| Disease | energy expenditure measurement | 4.36e-04 | 20 | 222 | 3 | EFO_0008005 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 4.61e-04 | 181 | 222 | 7 | DOID:684 (is_implicated_in) | |
| Disease | treatment resistant depression, response to antidepressant | 5.06e-04 | 21 | 222 | 3 | EFO_0009854, GO_0036276 | |
| Disease | Staphylococcal Infections | 5.55e-04 | 5 | 222 | 2 | C0038160 | |
| Disease | arecaidine measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0801112 | |
| Disease | Staphylococcus aureus infection | 5.55e-04 | 5 | 222 | 2 | C1318973 | |
| Disease | Intellectual Disability | TRIO ZNF462 PTCHD1 NF1 BRCA1 ARL13B PISD RAC3 MED13L SLC1A2 PACS1 | 6.18e-04 | 447 | 222 | 11 | C3714756 |
| Disease | sexual dimorphism measurement | ANKRD31 RIOK3 RAD54L2 ZNF462 NF1 CEP120 PLCB3 SMOX DOCK3 BAZ1B NUPR1 ATP13A2 RBM39 PACS1 GPATCH3 SLIT1 PARN SLFNL1 MYBPC3 | 7.47e-04 | 1106 | 222 | 19 | EFO_0021796 |
| Disease | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement | 7.57e-04 | 24 | 222 | 3 | EFO_0006821, EFO_0006826 | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 8.29e-04 | 6 | 222 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | Diffuse interstitial pulmonary fibrosis | 8.29e-04 | 6 | 222 | 2 | cv:C0085786 | |
| Disease | urinary tract infection (is_implicated_in) | 8.29e-04 | 6 | 222 | 2 | DOID:0080784 (is_implicated_in) | |
| Disease | mean arterial pressure, alcohol drinking | 8.87e-04 | 98 | 222 | 5 | EFO_0004329, EFO_0006340 | |
| Disease | Colorectal Carcinoma | OBSCN WNK1 VSTM4 NF1 ABCC8 FGFR3 IRS4 POLE EDA HIVEP3 TLR2 CXCL8 HDC FBXW7 | 9.36e-04 | 702 | 222 | 14 | C0009402 |
| Disease | Bipolar Disorder | DGKH ADARB1 ITPR1 NEDD4 CACNA1D POLG SLC1A2 PACS1 TLR2 ST8SIA2 CXCL8 | 1.05e-03 | 477 | 222 | 11 | C0005586 |
| Disease | Obstructive asymmetric septal hypertrophy | 1.15e-03 | 7 | 222 | 2 | C0597124 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.15e-03 | 7 | 222 | 2 | C0751337 | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 1.15e-03 | 7 | 222 | 2 | C0700053 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 1.20e-03 | 28 | 222 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | tuberculosis (is_implicated_in) | 1.20e-03 | 28 | 222 | 3 | DOID:399 (is_implicated_in) | |
| Disease | urate measurement | FRMD4B USP38 NFATC3 PLCB3 DOCK3 POLE BAZ1B ARHGAP17 CYTIP TBC1D10A CSPG4 SLC28A1 LRP4 ZNF518B HERC4 SORD | 1.30e-03 | 895 | 222 | 16 | EFO_0004531 |
| Disease | rhinitis (is_implicated_in) | 1.47e-03 | 30 | 222 | 3 | DOID:4483 (is_implicated_in) | |
| Disease | Frontotemporal Dementia With Motor Neuron Disease | 1.53e-03 | 8 | 222 | 2 | C3888102 | |
| Disease | ovarian cancer (implicated_via_orthology) | 1.53e-03 | 8 | 222 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | leprosy (is_implicated_in) | 1.53e-03 | 8 | 222 | 2 | DOID:1024 (is_implicated_in) | |
| Disease | vitamin D-dependent rickets (implicated_via_orthology) | 1.53e-03 | 8 | 222 | 2 | DOID:0080883 (implicated_via_orthology) | |
| Disease | breast carcinoma (is_marker_for) | 1.56e-03 | 66 | 222 | 4 | DOID:3459 (is_marker_for) | |
| Disease | coffee consumption | 1.77e-03 | 32 | 222 | 3 | EFO_0004330 | |
| Disease | Malignant Glioma | 1.94e-03 | 70 | 222 | 4 | C0555198 | |
| Disease | mixed gliomas | 1.94e-03 | 70 | 222 | 4 | C0259783 | |
| Disease | Heart Failure, Diastolic | 1.94e-03 | 33 | 222 | 3 | C1135196 | |
| Disease | Dyskeratosis congenita | 1.96e-03 | 9 | 222 | 2 | cv:C0265965 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 1.96e-03 | 9 | 222 | 2 | C0949658 | |
| Disease | interleukin 18 receptor accessory protein measurement | 1.96e-03 | 9 | 222 | 2 | EFO_0008179 | |
| Disease | diastolic blood pressure, alcohol drinking | 2.03e-03 | 118 | 222 | 5 | EFO_0004329, EFO_0006336 | |
| Disease | hepatitis C (is_marker_for) | 2.30e-03 | 35 | 222 | 3 | DOID:1883 (is_marker_for) | |
| Disease | lung cancer (is_implicated_in) | 2.38e-03 | 74 | 222 | 4 | DOID:1324 (is_implicated_in) | |
| Disease | HOYERAAL-HREIDARSSON SYNDROME | 2.44e-03 | 10 | 222 | 2 | C1846142 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | heart disease (is_marker_for) | 2.44e-03 | 10 | 222 | 2 | DOID:114 (is_marker_for) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of prostate | DAB2IP TLR6 ITPR1 FBLN1 BRCA1 USP7 VCP DDR1 KAT6A PDIA3 INTS4 CXCL8 | 2.59e-03 | 616 | 222 | 12 | C0376358 |
| Disease | Prostatic Neoplasms | DAB2IP TLR6 ITPR1 FBLN1 BRCA1 USP7 VCP DDR1 KAT6A PDIA3 INTS4 CXCL8 | 2.59e-03 | 616 | 222 | 12 | C0033578 |
| Disease | colorectal carcinoma (is_marker_for) | 2.70e-03 | 37 | 222 | 3 | DOID:0080199 (is_marker_for) | |
| Disease | Malignant Neoplasms | 2.88e-03 | 128 | 222 | 5 | C0006826 | |
| Disease | aortic measurement | 3.03e-03 | 251 | 222 | 7 | EFO_0020865 | |
| Disease | Cardiomyopathies | 3.08e-03 | 130 | 222 | 5 | C0878544 | |
| Disease | Malignant neoplasm of breast | ARHGEF38 OBSCN WNK1 NEDD4 ZC3H11A NF1 BRCA1 SMOX ZNF541 MRE11 PIGS TRMT2A SLC28A1 EHMT1 MRPL9 CXCL8 FBXW7 | 3.29e-03 | 1074 | 222 | 17 | C0006142 |
| Disease | multiple system atrophy | 3.38e-03 | 40 | 222 | 3 | EFO_1001050 | |
| Disease | Kidney Neoplasm | 3.38e-03 | 40 | 222 | 3 | C0022665 | |
| Disease | Inherited neuropathies | 3.38e-03 | 40 | 222 | 3 | C0598589 | |
| Disease | myotonia congenita (implicated_via_orthology) | 3.54e-03 | 12 | 222 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | gallbladder carcinoma (is_marker_for) | 3.54e-03 | 12 | 222 | 2 | DOID:4948 (is_marker_for) | |
| Disease | distal myopathy (implicated_via_orthology) | 3.54e-03 | 12 | 222 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | metabolite measurement | CYP2D7 ZNF462 SMOX SEMA3C NUPR1 WDFY4 ATP10D MYOF WDHD1 SLC28A1 HPS5 | 3.63e-03 | 560 | 222 | 11 | EFO_0004725 |
| Disease | autistic disorder (is_implicated_in) | 3.89e-03 | 42 | 222 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | Melanotic medulloblastoma | 4.15e-03 | 43 | 222 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 4.15e-03 | 43 | 222 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 4.15e-03 | 43 | 222 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 4.15e-03 | 43 | 222 | 3 | C0278876 | |
| Disease | Childhood Medulloblastoma | 4.15e-03 | 43 | 222 | 3 | C0278510 | |
| Disease | spleen volume | 4.15e-03 | 43 | 222 | 3 | EFO_0600047 | |
| Disease | autoimmune hepatitis (is_implicated_in) | 4.16e-03 | 13 | 222 | 2 | DOID:2048 (is_implicated_in) | |
| Disease | Nephronophthisis | 4.16e-03 | 13 | 222 | 2 | C0687120 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 4.16e-03 | 13 | 222 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Cardiotoxicity | 4.16e-03 | 13 | 222 | 2 | C0876994 | |
| Disease | ascending aortic diameter | 4.23e-03 | 140 | 222 | 5 | EFO_0021787 | |
| Disease | Glioma | 4.26e-03 | 87 | 222 | 4 | C0017638 | |
| Disease | Familial dilated cardiomyopathy | 4.43e-03 | 44 | 222 | 3 | C0340427 | |
| Disease | Malignant neoplasm of kidney | 4.72e-03 | 45 | 222 | 3 | C0740457 | |
| Disease | comparative body size at age 10, self-reported | 4.75e-03 | 420 | 222 | 9 | EFO_0009819 | |
| Disease | mean arterial pressure | ST7L CLCN6 FES USP7 CACNA1D SLC4A7 ARHGEF12 THSD7B HIVEP3 SLC28A1 | 4.75e-03 | 499 | 222 | 10 | EFO_0006340 |
| Disease | Hamman-Rich syndrome | 4.83e-03 | 14 | 222 | 2 | C0085786 | |
| Disease | Left ventricular noncompaction | 4.83e-03 | 14 | 222 | 2 | C1960469 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 4.83e-03 | 14 | 222 | 2 | C0677776 | |
| Disease | response to radiation, hearing loss, response to antineoplastic agent | 5.03e-03 | 46 | 222 | 3 | EFO_0004238, GO_0009314, GO_0097327 | |
| Disease | Neurodevelopmental Disorders | 5.40e-03 | 93 | 222 | 4 | C1535926 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 5.55e-03 | 15 | 222 | 2 | DOID:0050908 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVKVLKGHVLTRDLG | 706 | Q14137 | |
| KGILVFQLKRRPPDH | 336 | P55196 | |
| FQLKRRPPDHIPKKT | 341 | P55196 | |
| IHGLPLSPKRALFII | 1056 | Q6ZRH7 | |
| KKPHIIIATPGRLID | 141 | Q9H0S4 | |
| QRIEHLIGKKLPGFP | 376 | Q9H0S4 | |
| AQLRFPVPKGVLRIH | 376 | A0FGR8 | |
| LPGKTITPAHFQLLR | 2741 | Q96L91 | |
| HIRLQRTAKGKPVLA | 81 | Q9NRN7 | |
| AKHRIISPKVEPRTG | 281 | Q9Y6Y1 | |
| LGPTGKEVHALKRLR | 101 | Q6NXT1 | |
| ALEGPLAPLKLVRHK | 1231 | Q6UVK1 | |
| LSKTKRHLVPGAPFL | 371 | P0C0L5 | |
| RPKKLPLIQKRDTGH | 31 | Q9H2U9 | |
| KTIRGKHSVIPPAAR | 1286 | Q9UIG0 | |
| QIPGFREFLKKVHPR | 326 | P41180 | |
| LLSLFPGPHKLIQKR | 426 | Q9NXL2 | |
| VGTLQPKLKRFLRHP | 326 | Q7LC44 | |
| KAHTLILQPPSEKGR | 766 | Q9HD20 | |
| PLNVRKGHPLLVAVK | 641 | Q08345 | |
| KGHPLLVAVKILRPD | 646 | Q08345 | |
| LPRIHPELLAKKRGT | 106 | Q9P0M6 | |
| NKKGRVTPRHILLAV | 71 | O75367 | |
| LPNIHPELLAKKRGS | 106 | O75367 | |
| LKGRTETLKPDPHLR | 896 | Q5M775 | |
| IKPQKISIPDVGLHL | 1446 | Q09666 | |
| TTGIPKIVRVPHKCI | 201 | Q4L235 | |
| RHPRISGKPILVLAN | 116 | Q3SXY8 | |
| LRGHKRKLATPPAAQ | 1251 | Q9Y4B4 | |
| HITKFSLRQRRPPGK | 286 | Q9Y4F5 | |
| VNVKPLVTHRFPLEK | 316 | Q00796 | |
| HILRLEKPALEFKPT | 856 | Q9UPY3 | |
| KHLIPQESRRGLPLT | 1366 | Q6W2J9 | |
| RVPRVLKAHLGPETA | 36 | Q96MF4 | |
| ATQLHSKRRPKICGP | 671 | Q14004 | |
| RIKHSKPGSVPLVSE | 421 | Q9NV06 | |
| RQKIRHPSLGGLPIK | 606 | Q9P241 | |
| PEHGRKDTVIKPLLV | 891 | P01023 | |
| KRTGLLKQTHIAPKP | 256 | Q6IQ32 | |
| RFPLKKPIRHGSILN | 11 | Q9NZN5 | |
| SAIRGKIGLPHSIKL | 106 | Q14498 | |
| KAAKTPLKIHPLVRL | 501 | O94776 | |
| PHTPILLVGTKLDLR | 106 | P60763 | |
| KVHLKLRRPVTVPAG | 241 | Q8WWW0 | |
| SHLVPALRLPGRKLV | 581 | Q96HW7 | |
| PRNIKGKPEAHFSLI | 566 | P12883 | |
| LSPPKIHVSARSKLI | 401 | O95453 | |
| SFPGLLLHKEIKLPV | 836 | Q8N7Z5 | |
| FKHLRVVAKRAGQPP | 456 | Q5T089 | |
| PLRAINRAKGLKHVV | 976 | O60840 | |
| PAKRHLGLVVFRLKG | 401 | P19113 | |
| VSKLGPLPRILRDVH | 636 | Q5VWQ8 | |
| PPGLPRNVHVLKVKR | 446 | Q7Z5L7 | |
| LGPLHPSFNLVKIIR | 81 | Q96AD5 | |
| ESLPHLVKKALRVLP | 521 | O95256 | |
| HRKPSLLAHPGRLVK | 26 | P43627 | |
| GVKRPARLHTKPSQA | 221 | Q9NZM5 | |
| GDKLQKRPLIPFHHR | 476 | Q71F56 | |
| GSFHLKKVEQRTLPP | 901 | Q8N9B5 | |
| PRLKIPAHLRGKTSL | 871 | P46934 | |
| PKPHGIRALIASTIL | 2336 | Q14643 | |
| AQGLLPEAKKPRLLH | 466 | Q5TA45 | |
| NSKILVPPRTIHAKF | 276 | Q969R5 | |
| RKRSPKQGHLPTILE | 286 | Q8NAA5 | |
| AFKGVSLHRPAQPLK | 2156 | Q2LD37 | |
| KIGTLHTSPDLKVRP | 556 | Q9UPZ3 | |
| HFLEVKLGKRPQPVK | 51 | Q8WYK2 | |
| LVPPALRGLVRPHKK | 496 | Q9NY93 | |
| KILKPSIPLERIHFD | 386 | Q7Z6M2 | |
| HGEKLQPFGQLKRPR | 456 | Q96I76 | |
| RGKKRQEAPPHIFSI | 146 | P13535 | |
| PRLSFRKLVLLGPHV | 396 | Q96B70 | |
| RPGHRSRAPELVTKK | 186 | Q92614 | |
| KSVPEGPVQLLIRKH | 2821 | O15018 | |
| KLLAHVRPPVSKSGS | 386 | P08237 | |
| VVVHLLKLYKIGIPP | 566 | Q5GLZ8 | |
| KLKGTTELLPKRPQH | 551 | P54098 | |
| PHPAAPVTVKRKRVL | 1221 | Q07864 | |
| KDLGIPKVGHVKRIL | 1191 | Q86XP1 | |
| GKVPSHLLRSKITKP | 681 | P78563 | |
| PLLVSHLRSPRKIFG | 126 | Q9Y2T6 | |
| TVFPILRHLKQTKPE | 431 | Q9UPT5 | |
| DALRKPRLQKPITGH | 226 | O75161 | |
| GVHTPRQKRSTPLKE | 501 | Q6VY07 | |
| ERKIFGLSVLVPPHI | 2466 | Q96RW7 | |
| TVHLAPKLAVRTPLK | 606 | Q5VST9 | |
| KVPKVGRKFHRIGLP | 236 | Q8TCG2 | |
| LLKSPFSVHPKTGRI | 316 | P49642 | |
| PTPLDELRGHKALVK | 951 | Q01970 | |
| RQVRPIVGPFHAVLK | 661 | P23142 | |
| VKGHISIRSKSAPLP | 1851 | Q92794 | |
| RRPTSGLHPEDFIKK | 506 | P38398 | |
| LIKKRLYVGEPHRGP | 1061 | Q5T0Z8 | |
| VSKARKPPVCHGKRL | 241 | Q13642 | |
| ILPPKSLGIERIHFR | 611 | Q9Y2L6 | |
| VIKGSILQKHPRIRF | 181 | Q9NR50 | |
| PKVFKLHPRSGELEV | 281 | Q92838 | |
| IVPSHRRKIFPGLIL | 476 | Q08828 | |
| GIIVKHFPKLLPKVL | 831 | Q9NQ11 | |
| GRLKPKPIDVQVITH | 356 | P61158 | |
| VHPKPKLVRVLESLL | 366 | P51797 | |
| HIKVPFRGKPLPKVT | 626 | Q8N9C0 | |
| HVRLPLLSPKFLVGT | 256 | Q9Y2M5 | |
| HSKKVPPDGLLRRKS | 781 | Q8NHM5 | |
| RGKPNFTRHPSLIKL | 386 | A0AVK6 | |
| KLLPGDIHQIRKEFP | 386 | Q14185 | |
| IKLPIPIDRFRGSHL | 491 | Q8IZD9 | |
| LKLPIPVDKFRGAHI | 471 | Q8N1I0 | |
| GRRHIFKLKNPIKAP | 116 | Q8WUU5 | |
| VVSILEGRHFPKRPK | 11 | Q8N960 | |
| QKYPGLLKIIRHPER | 241 | Q9NY28 | |
| VILVLAIHPGNPKLK | 136 | P43004 | |
| IKTPKGTLPRLVDHV | 86 | Q5T1B0 | |
| GAIYKEHKPLVLRPV | 206 | Q8N3K9 | |
| PVTHQLKVEPIGRKL | 196 | Q4KMG0 | |
| IKRRKVIKPGFIHSP | 336 | Q969H0 | |
| LSGAFKKRRLPPVHI | 206 | Q92949 | |
| IRSYIGKPRLHLIPQ | 301 | Q8WWX0 | |
| SVRKQLLKFIPGLHR | 336 | O60759 | |
| PGDLRFRIKVVKHPI | 236 | Q9UBS4 | |
| HGPDVPVILGKRLLK | 1266 | Q6UXX5 | |
| KRFKRHQLTPGAHLP | 201 | Q9NU39 | |
| VKLPLLPHEVRGADK | 316 | O43681 | |
| KFLPQLPGHTKRRIR | 391 | Q9BZJ6 | |
| EIERILKHPVFPSGK | 1226 | A4D0S4 | |
| KPRFLVGLRSHLLPQ | 1156 | Q86VF2 | |
| LHRKIHVTPLIPGKS | 191 | Q9H0L4 | |
| GLLLHGPFARKPKRI | 181 | Q04741 | |
| NFHDGRPLPIERVKK | 311 | Q14527 | |
| KIIPSPGKEHFERVL | 66 | Q5M9N0 | |
| LGSPTVHKISRFPLK | 406 | P22607 | |
| FERLHPLVIKTGKPL | 176 | Q6UWU4 | |
| RKVKGNLILHLEPEP | 316 | Q9C0D2 | |
| KLVDPILRRHGLLPS | 386 | Q8N697 | |
| RPKPKTLHELLERIG | 251 | O75995 | |
| LPAPGADVKVHRARK | 191 | Q9H9B1 | |
| PLRAINRAKGLKHVV | 991 | Q01668 | |
| LSKTKRHLVPGAPFL | 371 | P0C0L4 | |
| RAGVHVRIPKLSKDP | 326 | P17540 | |
| QVIVKPRGLGHRKEL | 236 | O14654 | |
| HRKPSLLAHPGRLVK | 26 | Q14954 | |
| KLPFTVVHEREIPLK | 81 | Q96S52 | |
| PLTKKSGVVLHRAVP | 536 | P07332 | |
| VGRVLLLRVHKAPPV | 61 | O15296 | |
| PRGGRKKIRLVSHPE | 871 | Q9NZ71 | |
| APLQRRILEIGKKHG | 876 | O00268 | |
| PFKSLRHLELRGVPL | 106 | Q8N1F8 | |
| LAGKLIPVHQVRGLK | 326 | Q9Y5J1 | |
| ELGISIKVHEPPRKI | 101 | P82664 | |
| PPRAGLHSKVILAIR | 511 | Q8IZ69 | |
| FTPLHIKVKPKRVGI | 446 | Q9HCM9 | |
| SLKRLKPHVPLGRNC | 31 | Q969S9 | |
| IIKTPKGTRDLSPQH | 56 | P49590 | |
| KRKIPVFHNGSTPTL | 546 | Q9Y6M7 | |
| ALGLKSLTKHLPPLV | 161 | Q9BWM7 | |
| QTPHRPLILKTGSKF | 326 | P52630 | |
| IYPIHKRPLIVRIGT | 411 | Q99985 | |
| RKEPVKIAAPELHKG | 141 | Q92733 | |
| APSRVLHIRKLPGEV | 56 | Q9UKA9 | |
| RVIPKVTKHLLSNPV | 336 | Q9UIG8 | |
| TVPAKGHPERRLLSV | 146 | Q7L2K0 | |
| RPSPGGHERKLVTKL | 56 | O60356 | |
| AAGPSPHTLRRAVKK | 621 | Q68EM7 | |
| LKLHAAVTKIQVPRP | 116 | Q96NR3 | |
| SHLKKQAGPASVPLR | 126 | P30101 | |
| DPQRKALLHIFSGKP | 111 | D6RGX4 | |
| EKLSLKPHQGPVLRS | 986 | Q96QT6 | |
| LLTVPLIHFPARKAV | 341 | Q8IZM9 | |
| ELLPRTSPLKNKHFG | 141 | Q92186 | |
| VLPGLKVPHARKTGT | 26 | P40306 | |
| PGEAVKKHVGLLRIK | 276 | P49959 | |
| VPLKVIRLTVHTPKA | 316 | Q499Z3 | |
| LAHKIRAVEKKPIPR | 1766 | Q8NFU7 | |
| HKKPIDLRAIGKLPI | 241 | Q09428 | |
| HLPKLITPAEKGRDL | 161 | Q5VW32 | |
| QKTPTLAGRHVPLKI | 81 | Q96LM1 | |
| PHIPALAGKVLRFQK | 231 | A0A087X1C5 | |
| KVPLAGEGRKPRLHR | 61 | Q9BYD2 | |
| RAGIPCPTVVLLKKH | 341 | O14730 | |
| VPPSKRFLKHGQNIR | 391 | Q8IX90 | |
| ILPIKFPHLFTGKRT | 151 | O75351 | |
| VFKLHAKLGKPIPTL | 346 | Q9UPR6 | |
| RHIIAKLEEKRGPPL | 21 | Q15697 | |
| GLPVLKYHLLPRTKG | 196 | Q9NRZ7 | |
| ELPLRHPALFKAIGV | 221 | P55072 | |
| PPSKAERGHKVRLAV | 386 | Q5K4L6 | |
| ENVKTHPLIRPFKTL | 2646 | Q15413 | |
| EFQPGSIRLEKHPKL | 441 | Q6ZVD7 | |
| KQILHGDPLPLTRKS | 611 | O75717 | |
| RKSFKVHVPISIIPG | 661 | Q6ZQQ2 | |
| RKLKPQARPVCGLHS | 171 | Q9UG56 | |
| VPGITRHLTKRLPTK | 601 | O75152 | |
| KKRHGPLVAEAKILP | 1136 | P22105 | |
| DPQRKALLHIFSGKP | 111 | Q658T7 | |
| RPGLPTEKVAAIHRL | 346 | Q9NWM0 | |
| PHRRGLTPLSVKKED | 1541 | Q5T1R4 | |
| EKLPLLVIGKKRTPH | 226 | Q8IY51 | |
| ILRKVQHLIKESPGP | 466 | Q6ZS81 | |
| LKAVTREFEPLLKPH | 341 | Q3KQV9 | |
| RSHKRKLSGPPLQLQ | 246 | A8MX80 | |
| IRKPHSIRVETGLPA | 301 | Q8TBZ2 | |
| QHTKIRPKDVPGTLL | 1841 | P21359 | |
| LVFRVHIPQPSGKVL | 566 | Q12968 | |
| KSLILPPEHILKRGD | 421 | Q8TDW4 | |
| RRHSLKKVPVVPQGT | 791 | A0A0J9YWL9 | |
| GLLTLHREPVPLKSI | 6 | O00534 | |
| SRIPVTEKAPHKGII | 3731 | Q86WI1 | |
| SFPLKVRGIHLINEP | 186 | P49638 | |
| SSHPLPLKRVIVRKV | 11 | Q8NB14 | |
| RPRHITSLEVIKAGP | 51 | P02776 | |
| GVKVQVHTRRPKLPQ | 86 | Q9GZT3 | |
| FLRKRPIVPEHKKQP | 346 | Q5HYM0 | |
| LLGPKLRRFLKPQGH | 131 | O00337 | |
| RGLIHVPKDLPLKTK | 41 | Q9Y2C9 | |
| GPHGLKFLKPVELRL | 1701 | Q07157 | |
| LVLTGPKEKKVRFHP | 991 | Q9H6S0 | |
| RSHKRKLSGPPLQLQ | 246 | Q8N9G6 | |
| GKQLPSHKAILFVPR | 141 | Q9NQH7 | |
| IHKPVSLQPRGLINK | 406 | Q14694 | |
| EKLPPVLVLHLKRFV | 676 | Q14694 | |
| HGKALTLPRPRIVSL | 2106 | Q96JM2 | |
| ELELIKPHRAAKGAP | 291 | Q8IW00 | |
| QHRTFIKPKELEGLP | 491 | Q8ND82 | |
| GLPRLKHHLLPRTKG | 196 | Q9NRZ5 | |
| ILKGLQFLHTRTPPI | 331 | Q9H4A3 | |
| LKGLLFLHTRTPPII | 306 | Q9Y3S1 | |
| GKKLQHRTRAVIAPP | 196 | Q9C0I4 | |
| RKPPHVELKARPKLG | 1051 | Q8IWB9 | |
| RCSNKHLRALPKGIP | 746 | O75093 | |
| HLRALPKGIPKNVTE | 751 | O75093 | |
| HKKIRLRCQKGIPPS | 101 | Q9BXI6 | |
| PGKVETLTIRRLHIP | 306 | O60603 | |
| KGVKFLTLPPVLHLQ | 391 | Q93009 | |
| PPLLKSFLQERLGIH | 416 | Q6P2D8 | |
| GLIYEKISLPKVHPR | 391 | Q9UHD2 | |
| HIPKTAPATRQKGRR | 1606 | O75962 | |
| KREKIPPNHRKGILC | 36 | Q9H354 | |
| QTLHTGEKPVRFPLL | 541 | Q8TAF7 | |
| VALETLLLRGPHKPR | 1136 | Q9H0D2 | |
| ARKAHVATPVLIPKG | 761 | Q9C0D4 | |
| GKIVPKSLLLKPHQR | 81 | P53350 | |
| PKFIKELRVIESGPH | 46 | P10145 | |
| KRKVLIGSQLPHPFG | 936 | O75096 | |
| PPLVIKVIDHRQFGR | 1371 | Q9NZM1 | |
| PRHLRQTIQKKVGEP | 976 | Q14896 |